Customer Name | XXXXXXX | Customer Institutaion | XXXXXXX | Customer Email | XXXXXXX | Project ID | XXXXXXX |
---|---|
Salesperson | Kyle Navel | knavel@lcsciences.com |
Your reliable partner in genomics, transcriptomics and proteomics
Species name: Human
Latin name: Homo sapiens
Specimens: tissue
SampleID | species | cond1 |
Control_1 | hsa | Control |
Control_2 | hsa | Control |
Control_3 | hsa | Control |
Treatment_1 | hsa | Treatment |
Treatment_2 | hsa | Treatment |
Treatment_3 | hsa | Treatment |
Dababase | Web links | Version/date |
---|---|---|
Gene Orthology (GO) | https://www.ncbi.nlm.nih.gov/projects/SNP/ | 2016.12 |
KEGG | http://www.kegg.jp/ | 2017.06 |
Analysis item | Software | Version/date |
---|---|---|
Data normalization | Genespring | 14.8 |
GO and KEGG enrichment analysis | Perl scripts in house | NA |
Drawing tools | R,cytoacape | 3.3.0,3.5.1 |
Total RNA was extracted using Trizol reagent (Invitrogen, CA, USA) following the manufacturer's procedure. The total RNA quality and quantity were analysis of Bioanalyzer 2100 and RNA 6000 Nano LabChip Kit (Agilent, CA, USA) with RIN number >7.0. The sample labeling, microarray hybridization and washing were performed based on the manufacturer’s standard protocols. Briefly, total RNA were transcribed to double strand cDNA, then synthesized into cRNA and labeled with Cyanine-3-CTP. The labeled cRNAs were hybridized onto the microarray. After washing, the arrays were scanned by the Agilent Scanner G5761A (Agilent Technologies).
Feature Extraction software (version12.0.3.1, Agilent Technologies) was used to analyze array images to get raw data. Genespring (version14.8, Agilent Technologies) were employed to finish the basic analysis with the raw data. To begin with, the raw data was normalized with the quantile algorithm. The probes that at least 1 conditions out of 2 conditions have flags in “Detected” were chosen for further data analysis. Differentially expressed genes were then identified through fold change. The threshold set for up- and down-regulated genes was a fold change>= 2.0, or pvalue<=0.05. Afterwards, GO analysis and KEGG analysis were applied to determine the roles of these differentially expressed mRNA. Finally, Hierarchical Clustering was performed to display the distinguishable genes'expression pattern among samples.
Bioinformatics pipeline for mRNA microarray
Importing raw data into Genespring software (version14.8, Agilent), using quantile method to standardize data, including normalized signal values, sample detection and detailed annotation information.
ProbeName | Control_1_NormSignal | Control_2_NormSignal | Control_3_NormSignal | Treatment_1_NormSignal | Treatment_2_NormSignal | Treatment_3_NormSignal | Treatment_3_flags | Control_3_flags | Treatment_2_flags | Control_1_flags | Treatment_1_flags | Control_2_flags | PrimaryAccession | RefSeqAccession | GenbankAccession | UniGeneID | EntrezGeneID | GeneSymbol | GeneName | EnsemblID | Description | chr | start | end |
GE_BrightCorner | 18.50 | 18.35 | 18.23 | 18.37 | 18.36 | 18.13 | Detected | Detected | Detected | Detected | Detected | Detected | ||||||||||||
DarkCorner | 3.53 | 3.34 | 3.95 | 3.44 | 3.29 | 3.48 | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | ||||||||||||
A_21_P0014386 | 6.25 | 6.90 | 7.24 | 7.47 | 6.57 | 7.05 | Detected | Detected | Detected | Not Detected | Detected | Detected | ||||||||||||
A_33_P3396872 | 8.26 | 8.66 | 7.93 | 8.89 | 8.86 | 9.00 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_001105533|gb|AK025639|gb|BC030538|tc|THC2601673 | NM_001105533 | NM_001105533 | Hs.189652 | 79974 | CPED1 | cadherin-like and PC-esterase domain containing 1 | Homo sapiens cadherin-like and PC-esterase domain containing 1 (CPED1), transcript variant 2, mRNA [NM_001105533] | chr7 | 120901888 | 120901947 | |
A_33_P3267760 | 9.39 | 9.86 | 9.29 | 9.30 | 9.45 | 10.38 | Detected | Detected | Detected | Detected | Detected | Detected | ens|ENST00000378463 | 54880 | BCOR | BCL6 corepressor | ENST00000378463 | BCL6 corepressor [Source:HGNC Symbol;Acc:HGNC:20893] [ENST00000378463] | chrX | 39909128 | 39909069 | |||
A_32_P194264 | 10.14 | 11.98 | 11.74 | 10.24 | 11.31 | 10.00 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_001008708|ens|ENST00000295304|gb|HQ447717|gb|BC017941 | NM_001008708 | NM_001008708 | Hs.585944 | 494143 | CHAC2 | ChaC, cation transport regulator homolog 2 (E. coli) | ENST00000295304 | Homo sapiens ChaC, cation transport regulator homolog 2 (E. coli) (CHAC2), mRNA [NM_001008708] | chr2 | 54001454 | 54001513 |
A_23_P153745 | 10.99 | 12.22 | 10.13 | 11.28 | 11.04 | 11.74 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_006332|ens|ENST00000593731|ens|ENST00000600463|ens|ENST00000407280 | NM_006332 | NM_006332 | Hs.14623 | 10437 | IFI30 | interferon, gamma-inducible protein 30 | ENST00000593731 | Homo sapiens interferon, gamma-inducible protein 30 (IFI30), mRNA [NM_006332] | chr19 | 18288840 | 18288899 |
A_33_P3352837 | 9.79 | 9.35 | 9.41 | 9.41 | 9.47 | 9.64 | Detected | Detected | Detected | Detected | Detected | Detected | chr2 | 171521262 | 171521203 | |||||||||
A_21_P0011260 | 5.53 | 7.14 | 7.00 | 5.45 | 6.48 | 6.82 | Detected | Detected | Detected | Not Detected | Not Detected | Detected | ens|ENST00000618272|linc|TCONS_l2_00007928|gb|BI821606|tc|THC2662262 | Hs.592320 | ENST00000618272 | 603036639F1 NIH_MGC_115 Homo sapiens cDNA clone IMAGE:5177672 5', mRNA sequence [BI821606] | chr14 | 103675125 | 103675184 | |||||
A_33_P3235816 | 3.92 | 4.31 | 3.93 | 3.63 | 3.26 | 3.53 | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | ens|ENST00000436258|gb|BX647611|tc|THC2646539 | BX647611 | Hs.594815 | ENST00000436258 | DPY19L2 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:22305] [ENST00000436258] | chr7 | 35129516 | 35129457 | ||||
A_21_P0014180 | 9.55 | 9.86 | 10.20 | 9.56 | 9.75 | 10.53 | Detected | Detected | Detected | Detected | Detected | Detected | ens|ENST00000474396|tc|THC2637218 | XM_006715643 | XM_006715643 | 115330 | GPR146 | G protein-coupled receptor 146 | ENST00000474396 | G protein-coupled receptor 146 [Source:HGNC Symbol;Acc:HGNC:21718] [ENST00000474396] | chr7 | 1095841 | 1095900 | |
A_24_P944991 | 9.69 | 10.76 | 10.68 | 9.97 | 10.00 | 10.36 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_173829|ens|ENST00000513458|gb|BC127085|gb|BC127086 | NM_173829 | NM_173829 | Hs.69504 | 285672 | SREK1IP1 | SREK1-interacting protein 1 | ENST00000513458 | Homo sapiens SREK1-interacting protein 1 (SREK1IP1), mRNA [NM_173829] | chr5 | 64018946 | 64018887 |
A_21_P0006507 | 3.89 | 5.22 | 4.80 | 6.09 | 4.70 | 5.51 | Not Detected | Not Detected | Not Detected | Not Detected | Detected | Not Detected | linc|lnc-ARMCX4-1:1|linc|TCONS_00017209 | lnc-ARMCX4-1 | lnc-ARMCX4-1:1 | LNCipedia lincRNA (lnc-ARMCX4-1), lincRNA [lnc-ARMCX4-1:1] | chrX | 100672726 | 100672785 | |||||
A_23_P208706 | 11.13 | 11.84 | 11.71 | 11.33 | 11.73 | 11.56 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_138764|ref|NM_001291428|ref|NM_001291431|ref|NM_138761 | NM_138764 | NM_138764 | Hs.624291 | 581 | BAX | BCL2-associated X protein | ENST00000513545 | Homo sapiens BCL2-associated X protein (BAX), transcript variant sigma, mRNA [NM_138764] | chr19 | 49464904 | 49464963 |
A_33_P3388806 | 4.19 | 3.44 | 3.63 | 3.61 | 4.38 | 3.47 | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | ref|NM_001199327|gb|BC032865|ens|ENST00000370899|tc|THC2476487 | NM_001199327 | NM_001199327 | Hs.480085 | 100526835 | FPGT-TNNI3K | FPGT-TNNI3K readthrough | ENST00000370899 | Homo sapiens FPGT-TNNI3K readthrough (FPGT-TNNI3K), transcript variant 2, mRNA [NM_001199327] | chr1 | 74930515 | 74930574 |
A_33_P3324839 | 11.32 | 11.22 | 11.42 | 11.81 | 11.33 | 11.71 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_006772|ens|ENST00000418600|ens|ENST00000455687|gb|AL713634 | NM_006772 | NM_006772 | Hs.586264 | 8831 | SYNGAP1 | synaptic Ras GTPase activating protein 1 | ENST00000418600 | Homo sapiens synaptic Ras GTPase activating protein 1 (SYNGAP1), mRNA [NM_006772] | chr6 | 33420559 | 33420618 |
A_24_P333494 | 9.54 | 10.95 | 10.84 | 10.39 | 10.76 | 10.82 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_018994|ens|ENST00000375592|ref|XM_006710698|gb|BC006174 | NM_018994 | NM_018994 | Hs.522384 | 54455 | FBXO42 | F-box protein 42 | ENST00000375592 | Homo sapiens F-box protein 42 (FBXO42), mRNA [NM_018994] | chr1 | 16577198 | 16577139 |
A_22_P00006274 | 7.65 | 7.41 | 7.76 | 7.84 | 6.98 | 8.85 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NR_109772|ens|ENST00000413050|ens|ENST00000437181|linc|lnc-FAM75D1-1:3 | NR_109772 | NR_109772 | Hs.528628 | 101927502 | LOC101927502 | uncharacterized LOC101927502 | ENST00000413050 | Homo sapiens uncharacterized LOC101927502 (LOC101927502), long non-coding RNA [NR_109772] | chr9 | 84362930 | 84362989 |
A_23_P161615 | 12.28 | 12.86 | 12.98 | 11.72 | 11.96 | 11.47 | Detected | Detected | Detected | Detected | Detected | Detected | ens|ENST00000534785|ens|ENST00000527618|ens|ENST00000527850|gb|AK307831 | AK307831 | Hs.201897 | 23649 | POLA2 | polymerase (DNA directed), alpha 2, accessory subunit | ENST00000534785 | polymerase (DNA directed), alpha 2, accessory subunit [Source:HGNC Symbol;Acc:HGNC:30073] [ENST00000534785] | chr11 | 65062111 | 65063057 | |
A_33_P3384958 | 9.46 | 9.23 | 9.43 | 9.47 | 9.49 | 9.36 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_014839|ref|NM_001166252|ens|ENST00000457765|ens|ENST00000370185 | NM_014839 | NM_014839 | Hs.13245 | 9890 | LPPR4 | lipid phosphate phosphatase-related protein type 4 | ENST00000457765 | Homo sapiens lipid phosphate phosphatase-related protein type 4 (LPPR4), transcript variant 1, mRNA [NM_014839] | chr1 | 99771632 | 99771691 |
A_22_P00018955 | 6.54 | 5.82 | 5.33 | 4.79 | 4.34 | 5.27 | Not Detected | Not Detected | Not Detected | Detected | Not Detected | Detected | linc|lnc-SOX11-1:1|gb|BX089860|tc|THC2729651 | BX089860 | Hs.597532 | lnc-SOX11-1 | lnc-SOX11-1:1 | BX089860 NCI_CGAP_Brn23 Homo sapiens cDNA clone IMAGp998P014327 ; IMAGE:1704048, mRNA sequence [BX089860] | chr2 | 5847732 | 5847791 | |||
A_22_P00009547 | 6.45 | 3.39 | 3.52 | 3.57 | 3.27 | 3.39 | Not Detected | Not Detected | Not Detected | Detected | Not Detected | Not Detected | ref|NR_126414|linc|lnc-MAP2K6-3:1|gb|CB960713|tc|THC2717445 | NR_126414 | NR_126414 | Hs.569827 | 104355297 | ABCA9-AS1 | ABCA9 antisense RNA 1 | Homo sapiens ABCA9 antisense RNA 1 (ABCA9-AS1), long non-coding RNA [NR_126414] | chr17 | 67008185 | 67008244 | |
A_23_P218331 | 10.53 | 11.45 | 10.88 | 11.70 | 11.30 | 11.95 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_001017916|ref|NM_001017917|ref|NM_001915|ens|ENST00000581573 | NM_001017916 | NM_001017916 | Hs.355264 | 1534 | CYB561 | cytochrome b561 | ENST00000581573 | Homo sapiens cytochrome b561 (CYB561), transcript variant 2, mRNA [NM_001017916] | chr17 | 61510687 | 61510628 |
A_33_P6455786 | 13.90 | 14.30 | 14.26 | 14.60 | 14.49 | 14.32 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_058172|ref|NM_001286781|ref|NM_001286780|ens|ENST00000403729 | NM_058172 | NM_058172 | Hs.162963 | 118429 | ANTXR2 | anthrax toxin receptor 2 | ENST00000403729 | Homo sapiens anthrax toxin receptor 2 (ANTXR2), transcript variant 1, mRNA [NM_058172] | chr4 | 80822879 | 80822820 |
A_21_P0008705 | 8.68 | 8.20 | 8.84 | 9.02 | 8.93 | 8.84 | Detected | Detected | Detected | Detected | Detected | Detected | linc|lnc-POTEB-5:4|linc|lnc-POTEB-5:2|linc|TCONS_00023574|linc|TCONS_00023573 | lnc-POTEB-5 | lnc-POTEB-5:4 | LNCipedia lincRNA (lnc-POTEB-5), lincRNA [lnc-POTEB-5:4] | chr15 | 22541615 | 22541556 | |||||
A_22_P00016526 | 3.73 | 3.36 | 3.47 | 3.55 | 3.27 | 3.35 | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | ens|ENST00000547094|linc|lnc-TMTC3-4:1|linc|lnc-TMTC3-4:2|linc|TCONS_00020510 | Hs.148998 | ENST00000547094 | chr12 | 90343407 | 90343466 | ||||||
A_33_P3235207 | 3.72 | 4.50 | 3.45 | 4.23 | 5.52 | 3.34 | Not Detected | Not Detected | Detected | Not Detected | Not Detected | Not Detected | ref|NM_018018|ref|NM_001143824|ens|ENST00000547477|ens|ENST00000266579 | NM_018018 | NM_018018 | Hs.446077 | 55089 | SLC38A4 | solute carrier family 38, member 4 | ENST00000547477 | Homo sapiens solute carrier family 38, member 4 (SLC38A4), transcript variant 1, mRNA [NM_018018] | chr12 | 47173627 | 47173568 |
A_33_P3330991 | 15.13 | 14.72 | 14.47 | 14.69 | 14.53 | 14.87 | Detected | Detected | Detected | Detected | Detected | Detected | ref|XR_248772|gb|AK128451|tc|NP850545 | XR_248772 | XR_248772 | Hs.199368 | 100134237 | LOC100134237 | uncharacterized LOC100134237 | PREDICTED: Homo sapiens uncharacterized LOC100134237 (LOC100134237), misc_RNA [XR_248772] | chr1 | 32012152 | 32012211 | |
A_33_P3374299 | 9.43 | 9.01 | 9.12 | 9.47 | 9.28 | 10.14 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_173561|ens|ENST00000373164|ens|ENST00000470102|ens|ENST00000244565 | NM_173561 | NM_173561 | Hs.158357 | 222643 | UNC5CL | unc-5 homolog C (C. elegans)-like | ENST00000373164 | Homo sapiens unc-5 homolog C (C. elegans)-like (UNC5CL), mRNA [NM_173561] | chr6 | 40998222 | 40998163 |
A_33_P3274701 | 14.05 | 13.37 | 13.34 | 13.53 | 14.75 | 13.17 | Detected | Detected | Detected | Detected | Detected | Detected | gb|AK024162|tc|THC2483964 | AK024162 | Homo sapiens cDNA FLJ14100 fis, clone MAMMA1000855. [AK024162] | chr1 | 2144562 | 2144503 | ||||||
A_23_P83436 | 10.45 | 10.43 | 10.68 | 11.32 | 10.55 | 11.21 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_000285|ref|NM_001166056|ref|NM_001166057|ens|ENST00000591968 | NM_000285 | NM_000285 | Hs.36473 | 5184 | PEPD | peptidase D | ENST00000591968 | Homo sapiens peptidase D (PEPD), transcript variant 1, mRNA [NM_000285] | chr19 | 33877995 | 33877936 |
A_33_P3243138 | 8.49 | 8.76 | 9.01 | 8.42 | 9.03 | 8.56 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_182704|ens|ENST00000600586|ens|ENST00000335426|ens|ENST00000622070 | NM_182704 | NM_182704 | Hs.319284 | 348303 | SELV | selenoprotein V | ENST00000600586 | Homo sapiens selenoprotein V (SELV), mRNA [NM_182704] | chr19 | 40009729 | 40009788 |
A_22_P00008018 | 5.74 | 5.45 | 5.60 | 5.76 | 6.39 | 6.46 | Detected | Not Detected | Detected | Not Detected | Not Detected | Not Detected | ens|ENST00000579045|linc|lnc-IFT20-3:1|gb|BC082966|tc|THC2513242 | BC082966 | Hs.20588 | ENST00000579045 | Homo sapiens cDNA clone IMAGE:6341252. [BC082966] | chr17 | 26574222 | 26574163 | ||||
A_22_P00003937 | 3.63 | 3.33 | 3.36 | 3.49 | 3.26 | 3.28 | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | ens|ENST00000569945|linc|lnc-CGNL1-1:1|gb|BX641062|tc|THC2709601 | BX641062 | Hs.711270 | 145781 | GCOM1 | GRINL1A complex locus 1 | ENST00000569945 | GRINL1A complex locus 1 [Source:HGNC Symbol;Acc:HGNC:26424] [ENST00000569945] | chr15 | 57984823 | 57984882 | |
ERCC-00109_120 | 6.98 | 7.22 | 6.81 | 7.32 | 7.04 | 7.70 | Detected | Detected | Detected | Detected | Detected | Detected | DQ854998 | |||||||||||
A_33_P3293593 | 8.07 | 7.96 | 7.98 | 8.57 | 7.49 | 8.06 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_152479|ens|ENST00000311308|ens|ENST00000593586|gb|BC029539 | NM_152479 | NM_152479 | Hs.631572 | 148014 | TTC9B | tetratricopeptide repeat domain 9B | ENST00000311308 | Homo sapiens tetratricopeptide repeat domain 9B (TTC9B), mRNA [NM_152479] | chr19 | 40722025 | 40721966 |
A_22_P00008389 | 3.99 | 3.97 | 6.00 | 4.81 | 5.66 | 5.55 | Not Detected | Detected | Detected | Not Detected | Not Detected | Not Detected | ref|NM_001145545|ens|ENST00000505035|ens|ENST00000418886|linc|lnc-JMJD5-1:1 | NM_001145545 | NM_001145545 | Hs.120831 | 162083 | C16orf82 | chromosome 16 open reading frame 82 | ENST00000505035 | Homo sapiens chromosome 16 open reading frame 82 (C16orf82), mRNA [NM_001145545] | chr16 | 27080048 | 27080107 |
A_21_P0012208 | 6.55 | 9.30 | 9.03 | 7.27 | 8.37 | 7.60 | Detected | Detected | Detected | Detected | Detected | Detected | linc|lnc-C21orf58-1:1|linc|TCONS_l2_00017315|linc|TCONS_l2_00017538|gb|AK127572 | Hs.596577 | lnc-C21orf58-1 | lnc-C21orf58-1:1 | Homo sapiens cDNA FLJ45665 fis, clone CTONG2027959. [AK127572] | chr21 | 47875234 | 47875175 | ||||
A_23_P101084 | 7.48 | 6.95 | 7.01 | 6.70 | 7.38 | 7.07 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_032598|ref|NM_001170698|ref|NM_001170697|ref|NM_001170695 | NM_032598 | NM_032598 | Hs.351068 | 84690 | SPATA22 | spermatogenesis associated 22 | ENST00000573128 | Homo sapiens spermatogenesis associated 22 (SPATA22), transcript variant 2, mRNA [NM_032598] | chr17 | 3346555 | 3346496 |
A_23_P162120 | 13.60 | 14.00 | 13.51 | 13.56 | 13.61 | 13.42 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_006185|ref|NM_001286561|ref|NR_104476|ens|ENST00000616538 | NM_006185 | NM_006185 | Hs.325978 | 4926 | NUMA1 | nuclear mitotic apparatus protein 1 | ENST00000616538 | Homo sapiens nuclear mitotic apparatus protein 1 (NUMA1), transcript variant 1, mRNA [NM_006185] | chr11 | 71715302 | 71715118 |
A_24_P291426 | 10.19 | 10.66 | 10.79 | 10.68 | 10.30 | 10.49 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_016316|ref|NM_001037872|ens|ENST00000258428|ens|ENST00000393445 | NM_016316 | NM_016316 | Hs.443077 | 51455 | REV1 | REV1, polymerase (DNA directed) | ENST00000258428 | Homo sapiens REV1, polymerase (DNA directed) (REV1), transcript variant 1, mRNA [NM_016316] | chr2 | 100019124 | 100018768 |
A_32_P99311 | 6.03 | 6.97 | 6.26 | 7.64 | 7.18 | 6.18 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_181756|ref|NM_001207005|ens|ENST00000391958|gb|AK055310 | NM_181756 | NM_181756 | Hs.466891 | 353355 | ZNF233 | zinc finger protein 233 | ENST00000391958 | Homo sapiens zinc finger protein 233 (ZNF233), transcript variant 1, mRNA [NM_181756] | chr19 | 44779060 | 44779119 |
A_21_P0011409 | 6.98 | 8.69 | 8.19 | 8.09 | 8.08 | 8.66 | Detected | Detected | Detected | Detected | Detected | Detected | linc|TCONS_l2_00009502|gb|AK125393|tc|THC2508977 | Hs.586876 | XLOC_l2_004898 | BROAD Institute lincRNA (XLOC_l2_004898), lincRNA [TCONS_l2_00009502] | chr15 | 40983434 | 40983375 | |||||
A_24_P198629 | 9.39 | 9.68 | 9.36 | 9.73 | 9.45 | 10.15 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_001040616|ens|ENST00000559169|ref|XM_005254941|ref|XM_005254943 | NM_001040616 | NM_001040616 | Hs.105633 | 55180 | LINS | lines homolog (Drosophila) | ENST00000559169 | Homo sapiens lines homolog (Drosophila) (LINS), mRNA [NM_001040616] | chr15 | 101109837 | 101109778 |
A_19_P00322925 | 9.59 | 9.12 | 9.01 | 9.47 | 9.93 | 9.94 | Detected | Detected | Detected | Detected | Detected | Detected | ens|ENST00000607519|ens|ENST00000606884|linc|lnc-WRNIP1-2:31|linc|lnc-WRNIP1-2:32 | Hs.188825 | ENST00000607519 | GMDS antisense RNA 1 (head to head) [Source:HGNC Symbol;Acc:HGNC:48993] [ENST00000607519] | chr6 | 2481189 | 2481248 | |||||
A_22_P00025188 | 5.26 | 3.88 | 3.27 | 6.10 | 4.98 | 5.05 | Not Detected | Not Detected | Not Detected | Not Detected | Detected | Not Detected | ens|ENST00000512831|linc|lnc-NPY5R-2:1|linc|TCONS_00007672|tc|THC2642096 | ENST00000512831 | Q6NT14_HUMAN (Q6NT14) ZNF80 protein (Fragment), partial (13%) [THC2642096] | chr4 | 163662989 | 163663048 | ||||||
A_23_P52610 | 10.77 | 11.07 | 11.06 | 10.00 | 9.55 | 9.54 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_000107|ref|NM_001300734|ens|ENST00000378601|ens|ENST00000617847 | NM_000107 | NM_000107 | Hs.700338 | 1643 | DDB2 | damage-specific DNA binding protein 2, 48kDa | ENST00000378601 | Homo sapiens damage-specific DNA binding protein 2, 48kDa (DDB2), mRNA [NM_000107] | chr11 | 47260623 | 47260682 |
A_22_P00004622 | 3.49 | 4.65 | 5.30 | 4.99 | 3.45 | 4.60 | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | linc|lnc-CST7-2:1 | lnc-CST7-2 | lnc-CST7-2:1 | LNCipedia lincRNA (lnc-CST7-2), lincRNA [lnc-CST7-2:1] | chr20 | 24998440 | 24998499 | |||||
A_23_P2814 | 10.49 | 10.13 | 9.90 | 10.93 | 9.77 | 10.55 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_005905|ref|NM_001127217|ens|ENST00000379826|ens|ENST00000350148 | NM_005905 | NM_005905 | Hs.123119 | 4093 | SMAD9 | SMAD family member 9 | ENST00000379826 | Homo sapiens SMAD family member 9 (SMAD9), transcript variant b, mRNA [NM_005905] | chr13 | 37422872 | 37422813 |
A_23_P140602 | 12.90 | 13.49 | 12.85 | 13.17 | 13.11 | 13.29 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_001033088|ref|NR_028052|ens|ENST00000561573|gb|AK312641 | NM_001033088 | NM_001033088 | Hs.135471 | 51335 | NGRN | neugrin, neurite outgrowth associated | ENST00000561573 | Homo sapiens neugrin, neurite outgrowth associated (NGRN), transcript variant 2, mRNA [NM_001033088] | chr15 | 90814473 | 90814532 |
A_33_P3276112 | 12.92 | 12.79 | 12.19 | 12.47 | 13.59 | 11.70 | Detected | Detected | Detected | Detected | Detected | Detected | linc|lnc-CTD-2517M22.14.1-1:3|linc|lnc-CTD-2517M22.14.1-1:4|gb|AK126743|tc|THC2487449 | AK126743 | Hs.521937 | lnc-CTD-2517M22.14.1-1 | lnc-CTD-2517M22.14.1-1:3 | Homo sapiens cDNA FLJ44789 fis, clone BRACE3038760. [AK126743] | chr8 | 145722802 | 145722743 | |||
A_21_P0012896 | 7.80 | 7.77 | 9.10 | 8.13 | 8.44 | 7.96 | Detected | Detected | Detected | Detected | Detected | Detected | linc|TCONS_l2_00022830|tc|THC2775530 | XLOC_l2_011987 | BROAD Institute lincRNA (XLOC_l2_011987), lincRNA [TCONS_l2_00022830] | chr5 | 34124290 | 34124231 | ||||||
A_22_P00010379 | 7.62 | 8.01 | 8.47 | 7.50 | 8.03 | 8.11 | Detected | Detected | Detected | Detected | Detected | Detected | linc|lnc-MYL12A-1:1|gb|AK093324|tc|THC2533948 | AK093324 | Hs.589563 | lnc-MYL12A-1 | lnc-MYL12A-1:1 | Homo sapiens cDNA FLJ36005 fis, clone TESTI2015350. [AK093324] | chr18 | 3247111 | 3247170 | |||
A_23_P210939 | 13.51 | 15.04 | 14.51 | 14.56 | 14.45 | 14.64 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_181468|ref|NM_002212|ref|NM_181466|ref|NM_001267810 | NM_181468 | NM_181468 | Hs.743992 | 3692 | EIF6 | eukaryotic translation initiation factor 6 | ENST00000374450 | Homo sapiens eukaryotic translation initiation factor 6 (EIF6), transcript variant 2, mRNA [NM_181468] | chr20 | 33866998 | 33866939 |
A_24_P349039 | 8.67 | 10.61 | 10.31 | 9.09 | 10.26 | 9.63 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_020754|ens|ENST00000264245|ref|XM_006713714|ref|XM_005247671 | NM_020754 | NM_020754 | Hs.668218 | 57514 | ARHGAP31 | Rho GTPase activating protein 31 | ENST00000264245 | Homo sapiens Rho GTPase activating protein 31 (ARHGAP31), mRNA [NM_020754] | chr3 | 119136009 | 119136068 |
A_24_P143686 | 11.41 | 12.48 | 12.78 | 12.35 | 11.87 | 11.94 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_001080394|ref|NM_001282919|ref|NM_001282916|ref|NR_104581 | NM_001080394 | NM_001080394 | Hs.381058 | 23514 | SPIDR | scaffolding protein involved in DNA repair | ENST00000297423 | Homo sapiens scaffolding protein involved in DNA repair (SPIDR), transcript variant 1, mRNA [NM_001080394] | chr8 | 48642027 | 48647927 |
A_23_P115346 | 12.06 | 12.25 | 12.52 | 11.93 | 11.07 | 11.77 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_006893|ref|NM_001201478|ens|ENST00000468891|ens|ENST00000484492 | NM_006893 | NM_006893 | Hs.497581 | 1939 | EIF2D | eukaryotic translation initiation factor 2D | ENST00000468891 | Homo sapiens eukaryotic translation initiation factor 2D (EIF2D), transcript variant 1, mRNA [NM_006893] | chr1 | 206770531 | 206770472 |
A_22_P00010590 | 6.58 | 3.23 | 4.98 | 5.13 | 4.07 | 3.99 | Not Detected | Not Detected | Not Detected | Detected | Not Detected | Not Detected | ens|ENST00000553534|linc|lnc-NDRG2-3:1 | ENST00000553534 | chr14 | 21404323 | 21404264 | |||||||
A_22_P00014892 | 16.17 | 16.17 | 15.70 | 15.85 | 16.19 | 15.65 | Detected | Detected | Detected | Detected | Detected | Detected | ens|ENST00000521326|linc|lnc-SLC7A13-1:2|linc|lnc-SLC7A13-1:1|gb|BC038731 | BC038731 | Hs.561806 | ENST00000521326 | Homo sapiens cDNA clone IMAGE:5267578. [BC038731] | chr8 | 87355370 | 87355311 | ||||
A_21_P0014148 | 3.36 | 3.23 | 3.20 | 3.30 | 3.21 | 3.15 | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | gb|XR_108599 | XR_108599 | Hs.570950 | PREDICTED: Homo sapiens uncharacterized LOC100506329 (LOC100506329), misc_RNA [XR_108599] | chr5 | 50757933 | 50757992 | |||||
A_21_P0012259 | 11.51 | 11.72 | 11.88 | 11.09 | 12.97 | 10.38 | Detected | Detected | Compromised | Compromised | Detected | Detected | linc|TCONS_l2_00017650|linc|TCONS_l2_00017653 | XLOC_l2_009328 | BROAD Institute lincRNA (XLOC_l2_009328), lincRNA [TCONS_l2_00017650] | chr22 | 24663001 | 24663060 | ||||||
A_33_P3237393 | 3.35 | 3.22 | 3.19 | 3.29 | 3.20 | 3.14 | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | ref|NM_001300778|ref|NM_003440|ref|NM_001300777|ref|NM_001300776 | NM_001300778 | NM_001300778 | Hs.181552 | 7699 | ZNF140 | zinc finger protein 140 | Homo sapiens zinc finger protein 140 (ZNF140), transcript variant 4, mRNA [NM_001300778] | chr12 | 133684178 | 133684237 | |
A_23_P251486 | 6.93 | 7.30 | 6.61 | 6.57 | 6.47 | 6.79 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_006438|gb|AB002631|tc|THC2478678 | NM_006438 | NM_006438 | Hs.176615 | 10584 | COLEC10 | collectin sub-family member 10 (C-type lectin) | Homo sapiens collectin sub-family member 10 (C-type lectin) (COLEC10), mRNA [NM_006438] | chr8 | 120118876 | 120118935 | |
A_33_P3227880 | 7.91 | 8.14 | 8.01 | 8.40 | 6.76 | 8.23 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_001197247|ref|NM_001145009|ens|ENST00000396948|ens|ENST00000425234 | NM_001197247 | NM_001197247 | Hs.376046 | 11118 | BTN3A2 | butyrophilin, subfamily 3, member A2 | ENST00000396948 | Homo sapiens butyrophilin, subfamily 3, member A2 (BTN3A2), transcript variant 3, mRNA [NM_001197247] | chr6 | 26375985 | 26376044 |
A_33_P3267305 | 11.42 | 12.06 | 11.77 | 11.94 | 11.27 | 12.00 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_173595|ens|ENST00000267116|ens|ENST00000548241|gb|AK056831 | NM_173595 | NM_173595 | Hs.524506 | 283373 | ANKRD52 | ankyrin repeat domain 52 | ENST00000267116 | Homo sapiens ankyrin repeat domain 52 (ANKRD52), mRNA [NM_173595] | chr12 | 56631650 | 56631591 |
A_22_P00017513 | 3.87 | 6.42 | 5.66 | 5.77 | 5.07 | 5.42 | Not Detected | Not Detected | Not Detected | Not Detected | Detected | Detected | linc|lnc-WDFY2-1:1|tc|THC2661765|tc|THC2604700 | lnc-WDFY2-1 | lnc-WDFY2-1:1 | Q9BSH2_HUMAN (Q9BSH2) MARVELD3 protein (Fragment), partial (10%) [THC2604700] | chr13 | 52378813 | 52378872 | |||||
A_21_P0005768 | 4.93 | 5.36 | 6.49 | 3.29 | 3.62 | 3.13 | Not Detected | Detected | Not Detected | Not Detected | Not Detected | Not Detected | ref|NR_126028|ens|ENST00000519500|linc|lnc-KHDRBS3-4:4|linc|lnc-KHDRBS3-4:6 | NR_126028 | NR_126028 | 552853 | NCRNA00250 | non-protein coding RNA 250 | ENST00000519500 | Homo sapiens non-protein coding RNA 250 (NCRNA00250), long non-coding RNA [NR_126028] | chr8 | 135854504 | 135854698 | |
A_21_P0013237 | 9.52 | 8.86 | 8.90 | 9.40 | 9.31 | 9.09 | Detected | Detected | Detected | Detected | Detected | Detected | linc|lnc-VKORC1L1-2:1|linc|TCONS_l2_00025988 | lnc-VKORC1L1-2 | lnc-VKORC1L1-2:1 | LNCipedia lincRNA (lnc-VKORC1L1-2), lincRNA [lnc-VKORC1L1-2:1] | chr7 | 66006707 | 66006766 | |||||
A_21_P0003068 | 3.30 | 3.94 | 3.97 | 4.91 | 4.53 | 3.43 | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | linc|lnc-RP11-433C9.2.1-1:2|linc|TCONS_00006330 | lnc-RP11-433C9.2.1-1 | lnc-RP11-433C9.2.1-1:2 | LNCipedia lincRNA (lnc-RP11-433C9.2.1-1), lincRNA [lnc-RP11-433C9.2.1-1:2] | chr3 | 184119448 | 184144427 | |||||
A_33_P3333642 | 12.41 | 11.71 | 11.51 | 12.11 | 12.71 | 11.32 | Detected | Detected | Detected | Detected | Detected | Detected | ens|ENST00000399003|linc|lnc-MPEG1-1:1|gb|AK131315|tc|THC2487937 | AK131315 | Hs.533590 | ENST00000399003 | Homo sapiens cDNA FLJ16303 fis, clone PROST2019487. [AK131315] | chr11 | 59036408 | 59036349 | ||||
A_24_P42557 | 3.28 | 3.19 | 3.16 | 3.25 | 3.19 | 3.12 | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | ref|NM_001018036|ref|NM_001142626|ens|ENST00000342443|ens|ENST00000554435 | NM_001018036 | NM_001018036 | Hs.160411 | 7253 | TSHR | thyroid stimulating hormone receptor | ENST00000342443 | Homo sapiens thyroid stimulating hormone receptor (TSHR), transcript variant 2, mRNA [NM_001018036] | chr14 | 81557464 | 81558910 |
A_21_P0014207 | 8.59 | 7.70 | 7.70 | 8.41 | 7.12 | 8.76 | Detected | Detected | Detected | Detected | Detected | Detected | ref|XR_242321|ref|XR_250248|ref|XR_252275|tc|THC2645710 | XR_242321 | XR_242321 | 101927721 | LOC101927721 | uncharacterized LOC101927721 | PREDICTED: Homo sapiens uncharacterized LOC101927721 (LOC101927721), ncRNA [XR_242321] | chr7 | 100944565 | 100944624 | ||
A_22_P00021565 | 13.41 | 12.48 | 12.77 | 13.60 | 12.66 | 13.69 | Detected | Detected | Detected | Detected | Detected | Detected | ens|ENST00000531523|linc|lnc-RNF151-1:1|tc|THC2732461 | 677844 | SNORA78 | small nucleolar RNA, H/ACA box 78 | ENST00000531523 | small nucleolar RNA host gene 9 (non-protein coding) [Source:HGNC Symbol;Acc:HGNC:33102] [ENST00000531523] | chr16 | 2015451 | 2015510 | |||
A_21_P0000102 | 17.93 | 17.88 | 18.03 | 18.06 | 17.72 | 18.01 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_001190470|ens|ENST00000604882 | NM_001190470 | NM_001190470 | Hs.666077 | 100462981 | MTRNR2L2 | MT-RNR2-like 2 | ENST00000604882 | Homo sapiens MT-RNR2-like 2 (MTRNR2L2), mRNA [NM_001190470] | chr5 | 79945878 | 79945819 |
A_24_P401090 | 13.01 | 11.09 | 11.22 | 12.39 | 11.37 | 11.78 | Detected | Detected | Detected | Detected | Detected | Detected | ens|ENST00000442006 | ENST00000442006 | chr1 | 39175954 | 39176015 | |||||||
A_21_P0003288 | 3.26 | 3.17 | 3.14 | 3.23 | 3.18 | 3.11 | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | ens|ENST00000479244|linc|lnc-VGLL3-2:1|linc|lnc-VGLL3-2:2|linc|TCONS_00007195 | ENST00000479244 | chr3 | 86313788 | 86313729 | |||||||
A_24_P914625 | 10.53 | 10.80 | 11.02 | 10.71 | 10.31 | 10.51 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_207406|ref|NM_001159547|ens|ENST00000611697|ens|ENST00000504360 | NM_207406 | NM_207406 | Hs.120591 | 389206 | BEND4 | BEN domain containing 4 | ENST00000611697 | Homo sapiens BEN domain containing 4 (BEND4), transcript variant 1, mRNA [NM_207406] | chr4 | 42145792 | 42145733 |
A_33_P3393543 | 5.99 | 6.34 | 6.98 | 6.81 | 6.33 | 5.87 | Detected | Detected | Detected | Detected | Detected | Detected | gb|AL831916 | AL831916 | Hs.590968 | 400692 | LOC400692 | uncharacterized LOC400692 | Homo sapiens mRNA; cDNA DKFZp761D1918 (from clone DKFZp761D1918). [AL831916] | chr19 | 38036489 | 38036430 | ||
A_22_P00025856 | 8.42 | 8.43 | 8.03 | 8.52 | 7.87 | 8.30 | Detected | Detected | Detected | Detected | Detected | Detected | ens|ENST00000414038|linc|lnc-HECA-2:1|linc|TCONS_l2_00024448|linc|TCONS_l2_00025257 | 100132735 | LOC100132735 | uncharacterized LOC100132735 | ENST00000414038 | chr6 | 140176043 | 140176102 | ||||
A_23_P10559 | 8.54 | 7.96 | 8.30 | 8.13 | 7.94 | 7.71 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_001080395|ref|NM_004920|ens|ENST00000374792|ens|ENST00000570932 | NM_001080395 | NM_001080395 | Hs.514575 | 9625 | AATK | apoptosis-associated tyrosine kinase | ENST00000374792 | Homo sapiens apoptosis-associated tyrosine kinase (AATK), transcript variant 1, mRNA [NM_001080395] | chr17 | 79091254 | 79091195 |
A_23_P109636 | 10.62 | 10.15 | 10.10 | 11.04 | 10.70 | 11.23 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_015541|ens|ENST00000496559|ens|ENST00000383703|ens|ENST00000273261 | NM_015541 | NM_015541 | Hs.518055 | 26018 | LRIG1 | leucine-rich repeats and immunoglobulin-like domains 1 | ENST00000496559 | Homo sapiens leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1), mRNA [NM_015541] | chr3 | 66429656 | 66429597 |
A_22_P00011325 | 14.71 | 14.45 | 13.82 | 14.05 | 14.61 | 14.10 | Detected | Detected | Detected | Detected | Detected | Detected | linc|lnc-OST4-2:3|linc|lnc-OST4-2:2 | AK125769 | Hs.666730 | lnc-OST4-2 | lnc-OST4-2:3 | LNCipedia lincRNA (lnc-OST4-2), lincRNA [lnc-OST4-2:3] | chr2 | 27237428 | 27237369 | |||
A_22_P00000881 | 7.66 | 7.62 | 7.91 | 7.98 | 6.87 | 7.96 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_001010881|ens|ENST00000433342|linc|lnc-AGTRAP-1:1|ref|XM_006710068 | NM_001010881 | NM_001010881 | Hs.730573 | 284498 | C1orf167 | chromosome 1 open reading frame 167 | ENST00000433342 | Homo sapiens chromosome 1 open reading frame 167 (C1orf167), mRNA [NM_001010881] | chr1 | 11826106 | 11826165 |
A_24_P143301 | 10.99 | 11.08 | 10.85 | 11.60 | 11.51 | 12.08 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_181337|ens|ENST00000274766|gb|AF181722 | NM_181337 | NM_181337 | Hs.697888 | 353219 | KAAG1 | kidney associated antigen 1 | ENST00000274766 | Homo sapiens kidney associated antigen 1 (KAAG1), mRNA [NM_181337] | chr6 | 24357605 | 24357664 |
A_22_P00010333 | 9.28 | 9.05 | 9.43 | 9.44 | 8.57 | 9.20 | Detected | Detected | Detected | Detected | Detected | Detected | ens|ENST00000452888|linc|lnc-MYB-5:1|linc|TCONS_00011377 | ENST00000452888 | chr6 | 134957640 | 134957699 | |||||||
A_23_P215406 | 12.80 | 13.12 | 13.21 | 12.61 | 12.02 | 12.57 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_018890|ref|NM_006908|ens|ENST00000348035|gb|AK054993 | NM_018890 | NM_018890 | Hs.413812 | 5879 | RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | ENST00000348035 | Homo sapiens ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) (RAC1), transcript variant Rac1b, mRNA [NM_018890] | chr7 | 6443013 | 6443072 |
A_22_P00011550 | 4.79 | 3.14 | 3.22 | 5.26 | 4.60 | 4.36 | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | linc|lnc-PCDH18-1:4|linc|lnc-PCDH18-1:1|linc|TCONS_00009123|linc|TCONS_00008582 | Hs.738310 | lnc-PCDH18-1 | lnc-PCDH18-1:4 | LNCipedia lincRNA (lnc-PCDH18-1), lincRNA [lnc-PCDH18-1:4] | chr4 | 138628424 | 138628365 | ||||
A_21_P0003096 | 11.20 | 11.65 | 11.29 | 10.37 | 10.79 | 10.23 | Detected | Detected | Detected | Detected | Detected | Detected | linc|lnc-IL5RA-3:1|linc|TCONS_00006396 | lnc-IL5RA-3 | lnc-IL5RA-3:1 | LNCipedia lincRNA (lnc-IL5RA-3), lincRNA [lnc-IL5RA-3:1] | chr3 | 2139272 | 2139213 | |||||
A_21_P0013738 | 6.05 | 7.38 | 7.47 | 7.07 | 6.94 | 7.19 | Detected | Detected | Detected | Detected | Detected | Detected | linc|TCONS_l2_00030040|gb|DQ673932|gb|DQ673931 | XLOC_l2_015315 | BROAD Institute lincRNA (XLOC_l2_015315), lincRNA [TCONS_l2_00030040] | chr9 | 102128039 | 102127202 | ||||||
A_21_P0010286 | 6.18 | 6.62 | 6.54 | 7.02 | 7.33 | 7.43 | Detected | Detected | Detected | Detected | Detected | Detected | linc|lnc-PRDM15-1:1|linc|TCONS_00029147 | lnc-PRDM15-1 | lnc-PRDM15-1:1 | LNCipedia lincRNA (lnc-PRDM15-1), lincRNA [lnc-PRDM15-1:1] | chr21 | 43209077 | 43209018 | |||||
A_24_P336113 | 10.84 | 10.90 | 10.91 | 10.67 | 10.79 | 10.66 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_012295|ref|NM_001199281|ref|NM_001201429|ens|ENST00000620406 | NM_012295 | NM_012295 | Hs.517478 | 23523 | CABIN1 | calcineurin binding protein 1 | ENST00000620406 | Homo sapiens calcineurin binding protein 1 (CABIN1), transcript variant 2, mRNA [NM_012295] | chr22 | 24574422 | 24574481 |
A_33_P3373991 | 9.16 | 9.21 | 9.32 | 8.95 | 9.61 | 9.77 | Detected | Detected | Detected | Detected | Detected | Detected | ens|ENST00000437095|linc|lnc-ECEL1-1:1|linc|TCONS_00003513|gb|CN283607 | Hs.574600 | ENST00000437095 | 17000424984468 GRN_ES Homo sapiens cDNA 5', mRNA sequence [CN283607] | chr2 | 233285490 | 233285431 | |||||
A_33_P3266619 | 4.85 | 3.66 | 5.44 | 3.64 | 5.08 | 3.67 | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | ens|ENST00000547602|ref|XR_245977|ref|XR_247813|ref|XR_253055 | XR_245977 | XR_245977 | Hs.382689 | 728114 | LOC728114 | uncharacterized LOC728114 | ENST00000547602 | PREDICTED: Homo sapiens uncharacterized LOC728114 (LOC728114), misc_RNA [XR_245977] | chr12 | 48413644 | 48413585 |
A_33_P3361412 | 7.91 | 7.50 | 7.43 | 7.86 | 7.41 | 7.83 | Detected | Detected | Detected | Detected | Detected | Detected | ref|NM_018420|ens|ENST00000369502|ens|ENST00000369503|ref|XR_426622 | NM_018420 | NM_018420 | Hs.125482 | 55356 | SLC22A15 | solute carrier family 22, member 15 | ENST00000369502 | Homo sapiens solute carrier family 22, member 15 (SLC22A15), mRNA [NM_018420] | chr1 | 116569583 | 116569642 |
A_33_P3349927 | 7.36 | 7.11 | 7.03 | 7.29 | 7.44 | 7.25 | Detected | Detected | Detected | Detected | Detected | Detected | ens|ENST00000467220|gb|CR627036|tc|NP1276298 | CR627036 | 55112 | WDR60 | WD repeat domain 60 | ENST00000467220 | WD repeat domain 60 [Source:HGNC Symbol;Acc:HGNC:21862] [ENST00000467220] | chr7 | 158695283 | 158695342 | ||
A_22_P00023880 | 3.19 | 3.95 | 3.13 | 3.18 | 3.16 | 3.13 | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | linc|lnc-ANKMY2-1:1|tc|THC2776638 | lnc-ANKMY2-1 | lnc-ANKMY2-1:1 | Q3V199_MOUSE (Q3V199) 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4833413M20 product:basic leucine zipper and W2 domains 2, full insert sequence. (Fragment), partial (13%) [THC2776638] | chr7 | 16735584 | 16735525 | |||||
A_22_P00002594 | 6.69 | 7.44 | 6.68 | 7.02 | 6.84 | 6.29 | Detected | Detected | Detected | Detected | Detected | Detected | linc|lnc-C19orf54-1:1 | lnc-C19orf54-1 | lnc-C19orf54-1:1 | LNCipedia lincRNA (lnc-C19orf54-1), lincRNA [lnc-C19orf54-1:1] | chr19 | 41302261 | 41302202 | |||||
A_22_P00019357 | 3.19 | 3.12 | 3.14 | 3.19 | 3.81 | 3.27 | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | Not Detected | linc|lnc-UMPS-1:1|gb|BF727361 | BF727361 | Hs.581599 | lnc-UMPS-1 | lnc-UMPS-1:1 | by20d10.y1 Human Lens cDNA (Un-normalized, unamplified): BY Homo sapiens cDNA clone by20d10 5', mRNA sequence [BF727361] | chr3 | 124506545 | 124506604 | |||
A_22_P00009095 | 6.47 | 5.60 | 6.15 | 8.69 | 6.00 | 5.45 | Not Detected | Detected | Detected | Detected | Detected | Detected | linc|lnc-LHX2-2:1 | lnc-LHX2-2 | lnc-LHX2-2:1 | LNCipedia lincRNA (lnc-LHX2-2), lincRNA [lnc-LHX2-2:1] | chr9 | 126514156 | 126514215 |
document location:
summary/2_Normlized_Data/NormalizedData.xlsx
Box-whisker Plot uses the five statistics in the data: the minimum, the first quartile (25%), the median (50%), the third quartile (75% ) and the maximum value to describe the data, it also can roughly see whether the data has the symmetry, the degree of distribution and other information.
document location:
summary/2_Normlized_Data/RNA_expression_boxplot.png
Differential expression of mRNA based on normalized signals was analyzed by selectively using Fisher exact test, Chi-squared 2x2 test, Chi-squared nxn test, Student t test, or ANOVA based on the experiments design. The significance threshold was set to be 0.01 and 0.05 in each test.
ProbeName | Treatment_1 | Treatment_2 | Treatment_3 | Control_1 | Control_2 | Control_3 | foldChange | log2FoldChange | regulation | pval | significant | PrimaryAccession | EntrezGeneID | GeneSymbol | GeneName | Description | chr | start | end | GO | KEGG |
A_33_P3244165 | 19.49 | 19.49 | 19.49 | 19.49 | 19.49 | 19.49 | 1 | 0 | down | 0.00 | yes | ref|NR_003287|ref|NR_046235|gb|FB355642|gb|AK131444 | 100008589 | RNA28S5 | RNA, 28S ribosomal 5 | Homo sapiens RNA, 28S ribosomal 5 (RNA28S5), ribosomal RNA [NR_003287] | chrUn_gl000220 | 117142 | 117201 | ||
A_23_P137097 | 10.46 | 10.46 | 10.68 | 8.12 | 8 | 8.06 | 1.31 | 0.39 | up | 0.00 | yes | ref|NM_006517|ens|ENST00000587091|ref|XM_005262294|gb|U05315 | 6567 | SLC16A2 | solute carrier family 16, member 2 (thyroid hormone transporter) | Homo sapiens solute carrier family 16, member 2 (thyroid hormone transporter) (SLC16A2), mRNA [NM_006517] | chrX | 73753514 | 73753573 | GO:0005215(transporter activity);GO:0005887(integral to plasma membrane);GO:0006810(transport);GO:0008028(monocarboxylic acid transmembrane transporter activity);GO:0015293(symporter activity);GO:0015349(thyroid hormone transmembrane transporter activity);GO:0015718(monocarboxylic acid transport);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0034220(ion transmembrane transport);GO:0070327(thyroid hormone transport) | 04919(Thyroid hormone signaling pathway) |
A_32_P20454 | 12.19 | 12.12 | 12.19 | 11.11 | 11.20 | 11.10 | 1.09 | 0.13 | up | 0.00 | yes | ref|NM_001098398|ref|NM_004371|gb|CB240827 | 1314 | COPA | coatomer protein complex, subunit alpha | Homo sapiens coatomer protein complex, subunit alpha (COPA), transcript variant 1, mRNA [NM_001098398] | chr1 | 160258482 | 160258423 | GO:0005179(hormone activity);GO:0005198(structural molecule activity);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006886(intracellular protein transport);GO:0006890(retrograde vesicle-mediated transport, Golgi to ER);GO:0016020(membrane);GO:0030126(COPI vesicle coat);GO:0030157(pancreatic juice secretion);GO:0048205(COPI coating of Golgi vesicle);GO:0061024(membrane organization);GO:0070062(extracellular vesicular exosome) | 04080(Neuroactive ligand-receptor interaction) |
A_21_P0014329 | 12.18 | 12.21 | 12.17 | 11.16 | 11.10 | 11.27 | 1.09 | 0.12 | up | 0.00 | yes | ens|ENST00000563307|gb|BC053935|gb|AK090752|gb|AX746600 | 1459 | CSNK2A2 | casein kinase 2, alpha prime polypeptide | casein kinase 2, alpha prime polypeptide [Source:HGNC Symbol;Acc:HGNC:2459] [ENST00000563307] | chr16 | 58193554 | 58193495 | GO:0000278(mitotic cell cycle);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006468(protein phosphorylation);GO:0006915(apoptotic process);GO:0007411(axon guidance);GO:0016055(Wnt receptor signaling pathway);GO:0031519(PcG protein complex);GO:0047485(protein N-terminus binding);GO:0071174(mitotic cell cycle spindle checkpoint) | 03008(Ribosome biogenesis in eukaryotes|04310:Wnt signaling pathway|04064:NF-kappa B signaling pathway|04520:Adherens junction|04530:Tight junction|05162:Measles|05168:Herpes simplex infection|05169:Epstein-Barr virus infection) |
A_22_P00014850 | 10.50 | 10.74 | 10.68 | 9.12 | 8.97 | 8.95 | 1.18 | 0.24 | up | 0.00 | yes | ens|ENST00000607654|ens|ENST00000416861|linc|lnc-SLC4A3-1:1|gb|AK056734 | Homo sapiens cDNA FLJ32172 fis, clone PLACE6000555. [AK056734] | chr2 | 220551715 | 220551774 | |||||
A_23_P350574 | 11.73 | 11.71 | 11.78 | 11.26 | 11.24 | 11.31 | 1.04 | 0.06 | up | 0.00 | yes | ref|NM_001002901|ref|NM_001288831|ref|NM_001288832|ref|NM_001288829 | 127943 | FCRLB | Fc receptor-like B | Homo sapiens Fc receptor-like B (FCRLB), transcript variant 1, mRNA [NM_001002901] | chr1 | 161697713 | 161697772 | GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0050777(negative regulation of immune response) | |
A_33_P3298539 | 11.50 | 11.53 | 11.44 | 12.65 | 12.47 | 12.46 | 0.92 | -0.12 | down | 0.00 | yes | ref|NM_000039|ens|ENST00000236850|ens|ENST00000375323|ens|ENST00000375320 | 335 | APOA1 | apolipoprotein A-I | Homo sapiens apolipoprotein A-I (APOA1), mRNA [NM_000039] | chr11 | 116706700 | 116706641 | GO:0001523(retinoid metabolic process);GO:0001540(beta-amyloid binding);GO:0001932(regulation of protein phosphorylation);GO:0001935(endothelial cell proliferation);GO:0002576(platelet degranulation);GO:0002740(negative regulation of cytokine secretion involved in immune response);GO:0005515(protein binding);GO:0005543(phospholipid binding);GO:0005548(phospholipid transporter activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005769(early endosome);GO:0005788(endoplasmic reticulum lumen);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006656(phosphatidylcholine biosynthetic process);GO:0006695(cholesterol biosynthetic process);GO:0006898(receptor-mediated endocytosis);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007229(integrin-mediated signaling pathway);GO:0007584(response to nutrient);GO:0007596(blood coagulation);GO:0007603(phototransduction, visible light);GO:0008035(high-density lipoprotein particle binding);GO:0008203(cholesterol metabolic process);GO:0008211(glucocorticoid metabolic process);GO:0009986(cell surface);GO:0010804(negative regulation of tumor necrosis factor-mediated signaling pathway);GO:0010873(positive regulation of cholesterol esterification);GO:0010898(positive regulation of triglyceride catabolic process);GO:0010903(negative regulation of very-low-density lipoprotein particle remodeling);GO:0014012(peripheral nervous system axon regeneration);GO:0015485(cholesterol binding);GO:0017127(cholesterol transporter activity);GO:0018158(protein oxidation);GO:0018206(peptidyl-methionine modification);GO:0019899(enzyme binding);GO:0019915(lipid storage);GO:0030139(endocytic vesicle);GO:0030168(platelet activation);GO:0030300(regulation of intestinal cholesterol absorption);GO:0030301(cholesterol transport);GO:0030325(adrenal gland development);GO:0031100(organ regeneration);GO:0031102(neuron projection regeneration);GO:0031210(phosphatidylcholine binding);GO:0031410(cytoplasmic vesicle);GO:0031982(vesicle);GO:0032489(regulation of Cdc42 protein signal transduction);GO:0033344(cholesterol efflux);GO:0033700(phospholipid efflux);GO:0034115(negative regulation of heterotypic cell-cell adhesion);GO:0034190(apolipoprotein receptor binding);GO:0034191(apolipoprotein A-I receptor binding);GO:0034361(very-low-density lipoprotein particle);GO:0034364(high-density lipoprotein particle);GO:0034365(discoidal high-density lipoprotein particle);GO:0034366(spherical high-density lipoprotein particle);GO:0034375(high-density lipoprotein particle remodeling);GO:0034380(high-density lipoprotein particle assembly);GO:0034384(high-density lipoprotein particle clearance);GO:0034774(secretory granule lumen);GO:0035025(positive regulation of Rho protein signal transduction);GO:0042157(lipoprotein metabolic process);GO:0042158(lipoprotein biosynthetic process);GO:0042493(response to drug);GO:0042627(chylomicron);GO:0042632(cholesterol homeostasis);GO:0042802(identical protein binding);GO:0043534(blood vessel endothelial cell migration);GO:0043627(response to estrogen stimulus) | 03320(PPAR signaling pathway|04975:Fat digestion and absorption|04977:Vitamin digestion and absorption|05143:African trypanosomiasis) |
A_23_P73801 | 10.79 | 10.76 | 10.84 | 10.26 | 10.29 | 10.34 | 1.05 | 0.07 | up | 0.00 | yes | ref|NM_001006640|ref|NM_004780|ref|NM_001006639|ens|ENST00000619397 | 9338 | TCEAL1 | transcription elongation factor A (SII)-like 1 | Homo sapiens transcription elongation factor A (SII)-like 1 (TCEAL1), transcript variant 3, mRNA [NM_001006640] | chrX | 102885333 | 102885392 | GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-dependent) | |
A_23_P150238 | 12.96 | 12.87 | 12.98 | 13.59 | 13.67 | 13.57 | 0.95 | -0.07 | down | 0.00 | yes | ref|NM_031450|ref|NM_001135635|ens|ENST00000449692|ens|ENST00000438576 | 83638 | C11orf68 | chromosome 11 open reading frame 68 | Homo sapiens chromosome 11 open reading frame 68 (C11orf68), transcript variant 2, mRNA [NM_031450] | chr11 | 65684564 | 65684505 | ||
A_33_P3371425 | 12.85 | 12.85 | 12.81 | 13.24 | 13.19 | 13.27 | 0.97 | -0.04 | down | 0.00 | yes | ref|NM_020451|ref|NM_206926|ens|ENST00000494537|ens|ENST00000354177 | 57190 | SEPN1 | selenoprotein N, 1 | Homo sapiens selenoprotein N, 1 (SEPN1), transcript variant 1, mRNA [NM_020451] | chr1 | 26142117 | 26142176 | GO:0003674(molecular_function);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005789(endoplasmic reticulum membrane);GO:0008150(biological_process) | |
A_22_P00013179 | 11.32 | 11.15 | 11.38 | 12.53 | 12.45 | 12.38 | 0.91 | -0.14 | down | 0.00 | yes | linc|lnc-RNF144B-1:1|gb|AK098665|tc|THC2543869 | lnc-RNF144B-1 | lnc-RNF144B-1:1 | Homo sapiens cDNA FLJ25799 fis, clone TST07088. [AK098665] | chr6 | 18536161 | 18536220 | |||
A_19_P00325810 | 7.79 | 7.90 | 7.62 | 9 | 8.94 | 8.95 | 0.87 | -0.21 | down | 0.00 | yes | ref|NR_027005|ens|ENST00000484801|gb|AK090984|tc|THC2502979 | 80759 | KHDC1 | KH homology domain containing 1 | Homo sapiens KH homology domain containing 1 (KHDC1), transcript variant 3, non-coding RNA [NR_027005] | chr6 | 73984736 | 73984677 | GO:0003723(RNA binding);GO:0016021(integral to membrane) | |
A_21_P0009635 | 7.72 | 7.81 | 7.85 | 8.40 | 8.35 | 8.41 | 0.93 | -0.11 | down | 0.00 | yes | linc|lnc-RTTN-2:1|linc|TCONS_00026726 | lnc-RTTN-2 | lnc-RTTN-2:1 | LNCipedia lincRNA (lnc-RTTN-2), lincRNA [lnc-RTTN-2:1] | chr18 | 68004781 | 68004574 | |||
A_22_P00015934 | 9.73 | 9.82 | 9.80 | 9.15 | 9.03 | 9.16 | 1.07 | 0.10 | up | 0.00 | yes | linc|lnc-TCP11L2-2:1|gb|BG199486|tc|THC2776961 | lnc-TCP11L2-2 | lnc-TCP11L2-2:1 | RST18770 Athersys RAGE Library Homo sapiens cDNA, mRNA sequence [BG199486] | chr12 | 106497094 | 106497153 | |||
A_24_P68631 | 13.57 | 13.50 | 13.52 | 14.26 | 14.31 | 14.45 | 0.94 | -0.08 | down | 0.00 | yes | ref|NM_175065|ens|ENST00000331128|gb|BC172330|gb|BC132811 | 317772 | HIST2H2AB | histone cluster 2, H2ab | Homo sapiens histone cluster 2, H2ab (HIST2H2AB), mRNA [NM_175065] | chr1 | 149859244 | 149859185 | GO:0000786(nucleosome);GO:0003674(molecular_function);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0008150(biological_process);GO:0046982(protein heterodimerization activity);GO:0070062(extracellular vesicular exosome) | 05322(Systemic lupus erythematosus|05034:Alcoholism) |
A_23_P88278 | 7.72 | 7.52 | 7.63 | 6.80 | 6.82 | 6.74 | 1.12 | 0.17 | up | 0.00 | yes | ref|NM_020366|ens|ENST00000400017|ens|ENST00000553927|ens|ENST00000555322 | 57096 | RPGRIP1 | retinitis pigmentosa GTPase regulator interacting protein 1 | Homo sapiens retinitis pigmentosa GTPase regulator interacting protein 1 (RPGRIP1), mRNA [NM_020366] | chr14 | 21813303 | 21816336 | GO:0005515(protein binding);GO:0005930(axoneme);GO:0007601(visual perception);GO:0032391(photoreceptor connecting cilium);GO:0042462(eye photoreceptor cell development);GO:0050896(response to stimulus);GO:0060041(retina development in camera-type eye) | |
A_33_P3808371 | 12.09 | 12.04 | 12.04 | 11.71 | 11.74 | 11.67 | 1.03 | 0.04 | up | 0.00 | yes | gb|AL833480|gb|AK125186|tc|THC2502358|tc|THC2566333 | 283911 | LOC283911 | uncharacterized LOC283911 | Homo sapiens mRNA; cDNA DKFZp686C2429 (from clone DKFZp686C2429). [AL833480] | chr16 | 34388638 | 34388697 | ||
A_33_P3382423 | 8.37 | 8.30 | 8.32 | 7.76 | 7.72 | 7.61 | 1.08 | 0.11 | up | 0.00 | yes | ref|NM_182498|ens|ENST00000300811|gb|BC045799|tc|THC2472513 | 126299 | ZNF428 | zinc finger protein 428 | Homo sapiens zinc finger protein 428 (ZNF428), mRNA [NM_182498] | chr19 | 44111451 | 44111392 | GO:0046872(metal ion binding) | |
A_23_P68730 | 12.42 | 12.37 | 12.51 | 11.85 | 11.76 | 11.83 | 1.05 | 0.07 | up | 0.00 | yes | ref|NM_003681|ens|ENST00000291565|ens|ENST00000468090|ref|XM_005261198 | 8566 | PDXK | pyridoxal (pyridoxine, vitamin B6) kinase | Homo sapiens pyridoxal (pyridoxine, vitamin B6) kinase (PDXK), mRNA [NM_003681] | chr21 | 45181808 | 45181867 | GO:0000287(magnesium ion binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006766(vitamin metabolic process);GO:0006767(water-soluble vitamin metabolic process);GO:0008270(zinc ion binding);GO:0008283(cell proliferation);GO:0008478(pyridoxal kinase activity);GO:0009443(pyridoxal 5'-phosphate salvage);GO:0016310(phosphorylation);GO:0030170(pyridoxal phosphate binding);GO:0030955(potassium ion binding);GO:0031402(sodium ion binding);GO:0031403(lithium ion binding);GO:0042803(protein homodimerization activity);GO:0042816(vitamin B6 metabolic process);GO:0042823(pyridoxal phosphate biosynthetic process);GO:0044281(small molecule metabolic process);GO:0070062(extracellular vesicular exosome) | 00750(Vitamin B6 metabolism) |
A_33_P3214705 | 12.72 | 13.05 | 12.43 | 15.40 | 15.38 | 15.08 | 0.83 | -0.26 | down | 0.00 | yes | ref|NM_001100418|ref|NM_001100419|ens|ENST00000597371|ens|ENST00000598375 | 55049 | C19orf60 | chromosome 19 open reading frame 60 | Homo sapiens chromosome 19 open reading frame 60 (C19orf60), transcript variant 1, mRNA [NM_001100418] | chr19 | 18701688 | 18702918 | GO:0005515(protein binding) | |
A_22_P00014845 | 10.94 | 11.13 | 11.06 | 10.31 | 10.22 | 10.19 | 1.08 | 0.11 | up | 0.00 | yes | linc|lnc-SLC4A10-2:1|tc|THC2638507 | lnc-SLC4A10-2 | lnc-SLC4A10-2:1 | S79876 dipeptidyl peptidase IV {Homo sapiens} (exp=-1; wgp=0; cg=0), partial (94%) [THC2638507] | chr2 | 162929769 | 162929828 | |||
A_23_P31725 | 11.95 | 12.07 | 12.06 | 11.31 | 11.44 | 11.35 | 1.06 | 0.08 | up | 0.00 | yes | ref|NM_001715|ens|ENST00000526097|ens|ENST00000259089|ref|XM_005272390 | 640 | BLK | BLK proto-oncogene, Src family tyrosine kinase | Homo sapiens BLK proto-oncogene, Src family tyrosine kinase (BLK), mRNA [NM_001715] | chr8 | 11421858 | 11421917 | GO:0004713(protein tyrosine kinase activity);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0005102(receptor binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0030217(T cell differentiation);GO:0031234(extrinsic to internal side of plasma membrane);GO:0032024(positive regulation of insulin secretion);GO:0035556(intracellular signal transduction);GO:0038083(peptidyl-tyrosine autophosphorylation);GO:0042127(regulation of cell proliferation);GO:0045087(innate immune response);GO:0050853(B cell receptor signaling pathway);GO:0071375(cellular response to peptide hormone stimulus) | |
A_21_P0014618 | 9.63 | 9.83 | 9.71 | 8.85 | 8.71 | 8.86 | 1.10 | 0.14 | up | 0.00 | yes | ref|XR_246615|ref|XR_249555|ref|XR_251536|linc|lnc-ATP5I-1:1 | 101928521 | LOC101928521 | uncharacterized LOC101928521 | PREDICTED: Homo sapiens uncharacterized LOC101928521 (RP11-1191J2.2), ncRNA [XR_246615] | chr4 | 647379 | 647320 | ||
A_23_P64611 | 8.43 | 8.81 | 8.91 | 6.65 | 6.89 | 6.75 | 1.29 | 0.37 | up | 0.00 | yes | ref|NM_176798|ref|NM_001277204|ref|NM_176796|ref|NM_001277205 | 5031 | P2RY6 | pyrimidinergic receptor P2Y, G-protein coupled, 6 | Homo sapiens pyrimidinergic receptor P2Y, G-protein coupled, 6 (P2RY6), transcript variant 2, mRNA [NM_176798] | chr11 | 73008625 | 73008684 | GO:0004930(G-protein coupled receptor activity);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0007200(phospholipase C-activating G-protein coupled receptor signaling pathway);GO:0014911(positive regulation of smooth muscle cell migration);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0030321(transepithelial chloride transport);GO:0035589(G-protein coupled purinergic nucleotide receptor signaling pathway);GO:0045028(G-protein coupled purinergic nucleotide receptor activity);GO:0045029(UDP-activated nucleotide receptor activity) | 04080(Neuroactive ligand-receptor interaction) |
A_22_P00006060 | 11.95 | 11.65 | 11.68 | 13.20 | 13.20 | 13.01 | 0.90 | -0.16 | down | 0.00 | yes | linc|lnc-FAM131B-1:2|gb|AB074268|gb|CU690101|tc|THC2631669 | lnc-FAM131B-1 | lnc-FAM131B-1:2 | Homo sapiens primary neuroblastoma cDNA, clone:Nbla10687, full insert sequence. [AB074268] | chr7 | 142983199 | 142983140 | |||
A_33_P3326872 | 8.58 | 8.69 | 8.67 | 7.86 | 7.94 | 8.03 | 1.09 | 0.12 | up | 0.00 | yes | chr13 | 23411111 | 23411052 | |||||||
A_23_P351844 | 10.49 | 10.09 | 10.07 | 11.91 | 11.91 | 11.78 | 0.86 | -0.22 | down | 0.00 | yes | ref|NM_001764|ens|ENST00000368168|ens|ENST00000451207|gb|M28826 | 910 | CD1B | CD1b molecule | Homo sapiens CD1b molecule (CD1B), mRNA [NM_001764] | chr1 | 158297780 | 158297740 | GO:0005515(protein binding);GO:0005765(lysosomal membrane);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0009986(cell surface);GO:0010008(endosome membrane);GO:0016021(integral to membrane);GO:0030881(beta-2-microglobulin binding);GO:0030883(endogenous lipid antigen binding);GO:0030884(exogenous lipid antigen binding);GO:0048007(antigen processing and presentation, exogenous lipid antigen via MHC class Ib);GO:0071723(lipopeptide binding) | 04640(Hematopoietic cell lineage) |
A_23_P212458 | 13.78 | 13.76 | 13.69 | 13.40 | 13.38 | 13.34 | 1.03 | 0.04 | up | 0.00 | yes | ref|NM_013336|ens|ENST00000424880|ens|ENST00000243253|ens|ENST00000483956 | 29927 | SEC61A1 | Sec61 alpha 1 subunit (S. cerevisiae) | Homo sapiens Sec61 alpha 1 subunit (S. cerevisiae) (SEC61A1), mRNA [NM_013336] | chr3 | 127789960 | 127790019 | GO:0002474(antigen processing and presentation of peptide antigen via MHC class I);GO:0002479(antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent);GO:0005515(protein binding);GO:0005791(rough endoplasmic reticulum);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0006620(posttranslational protein targeting to membrane);GO:0007029(endoplasmic reticulum organization);GO:0016020(membrane);GO:0016049(cell growth);GO:0030176(integral to endoplasmic reticulum membrane);GO:0034341(response to interferon-gamma);GO:0042590(antigen processing and presentation of exogenous peptide antigen via MHC class I);GO:0043022(ribosome binding);GO:0045047(protein targeting to ER) | 03060(Protein export|04141:Protein processing in endoplasmic reticulum|04145:Phagosome|05110:Vibrio cholerae infection) |
A_32_P213624 | 11.77 | 12.10 | 12.15 | 10.41 | 10.41 | 10.61 | 1.15 | 0.20 | up | 0.00 | yes | ref|NM_001130841|ref|NM_003729|ens|ENST00000370128|ref|XM_005271298 | 8634 | RTCA | RNA 3'-terminal phosphate cyclase | Homo sapiens RNA 3'-terminal phosphate cyclase (RTCA), transcript variant 1, mRNA [NM_001130841] | chr1 | 100758204 | 100758263 | GO:0003723(RNA binding);GO:0003963(RNA-3'-phosphate cyclase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006396(RNA processing) | |
A_24_P392110 | 13.42 | 13.21 | 13.64 | 11.29 | 11.70 | 11.34 | 1.17 | 0.23 | up | 0.00 | yes | ref|NM_182707|ref|NM_001130167|ref|NM_001130168|ref|NM_021016 | 440533 | PSG8 | pregnancy specific beta-1-glycoprotein 8 | Homo sapiens pregnancy specific beta-1-glycoprotein 8 (PSG8), transcript variant 1, mRNA [NM_182707] | chr19 | 43258549 | 43258490 | GO:0005576(extracellular region) | |
A_22_P00012456 | 15.21 | 15.22 | 15.17 | 15.60 | 15.61 | 15.72 | 0.97 | -0.04 | down | 0.00 | yes | ref|NR_027687|ref|NR_027686|ens|ENST00000431158|ens|ENST00000444463 | 284739 | LINC00176 | long intergenic non-protein coding RNA 176 | Homo sapiens long intergenic non-protein coding RNA 176 (LINC00176), transcript variant 2, long non-coding RNA [NR_027687] | chr20 | 62669496 | 62669555 | ||
A_23_P103968 | 12.47 | 12.25 | 12.21 | 13.17 | 13.19 | 13.25 | 0.93 | -0.10 | down | 0.00 | yes | ref|NM_012067|ens|ENST00000361640|gb|AF040639|gb|EU176235 | 22977 | AKR7A3 | aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) | Homo sapiens aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) (AKR7A3), mRNA [NM_012067] | chr1 | 19611233 | 19610614 | GO:0004033(aldo-keto reductase (NADP) activity);GO:0005829(cytosol);GO:0006081(cellular aldehyde metabolic process);GO:0006805(xenobiotic metabolic process);GO:0009055(electron carrier activity);GO:0044281(small molecule metabolic process);GO:0055114(oxidation-reduction process);GO:0070062(extracellular vesicular exosome) | 00980(Metabolism of xenobiotics by cytochrome P450) |
A_24_P357726 | 12.61 | 12.55 | 12.96 | 10.29 | 10.85 | 10.49 | 1.21 | 0.27 | up | 0.00 | yes | ref|NM_182707|ref|NM_001130167|ref|NM_001130168|ref|NM_002782 | 440533 | PSG8 | pregnancy specific beta-1-glycoprotein 8 | Homo sapiens pregnancy specific beta-1-glycoprotein 8 (PSG8), transcript variant 1, mRNA [NM_182707] | chr19 | 43259206 | 43259147 | GO:0005576(extracellular region) | |
A_33_P3330972 | 9.59 | 9.90 | 9.73 | 8.81 | 8.79 | 8.73 | 1.11 | 0.15 | up | 0.00 | yes | chr4 | 624773 | 624714 | |||||||
A_23_P124427 | 9.41 | 9.44 | 9.56 | 10.63 | 11.06 | 10.93 | 0.87 | -0.20 | down | 0.00 | yes | ref|NM_012224|ref|NM_001199397|ref|NM_001199398|ref|NM_001199400 | 4750 | NEK1 | NIMA-related kinase 1 | Homo sapiens NIMA-related kinase 1 (NEK1), transcript variant 2, mRNA [NM_012224] | chr4 | 170315411 | 170315352 | GO:0000165(MAPK cascade);GO:0000187(activation of MAPK activity);GO:0000242(pericentriolar material);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004708(MAP kinase kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0006974(response to DNA damage stimulus);GO:0007067(mitosis);GO:0010212(response to ionizing radiation);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0042384(cilium assembly);GO:0046872(metal ion binding);GO:0051301(cell division) | |
A_21_P0010240 | 7.37 | 7.43 | 7.59 | 8.22 | 8.17 | 8.14 | 0.91 | -0.13 | down | 0.00 | yes | ref|XR_425268|ref|XR_430370|ref|XR_433641|linc|lnc-CHAF1B-1:1 | 102724630 | LOC102724630 | uncharacterized LOC102724630 | PREDICTED: Homo sapiens uncharacterized LOC102724630 (LOC102724630), ncRNA [XR_425268] | chr21 | 37757138 | 37757197 | ||
A_32_P86763 | 14.47 | 14.54 | 14.34 | 13.66 | 13.78 | 13.77 | 1.05 | 0.07 | up | 0.00 | yes | ref|NM_004613|ens|ENST00000469269|gb|AK126508|gb|AK058031 | 7052 | TGM2 | transglutaminase 2 | Homo sapiens transglutaminase 2 (TGM2), transcript variant 1, mRNA [NM_004613] | chr20 | 36757912 | 36757853 | GO:0001974(blood vessel remodeling);GO:0003810(protein-glutamine gamma-glutamyltransferase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0018153(isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine);GO:0019904(protein domain specific binding);GO:0032471(reduction of endoplasmic reticulum calcium ion concentration);GO:0043065(positive regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade);GO:0043277(apoptotic cell clearance);GO:0045785(positive regulation of cell adhesion);GO:0046872(metal ion binding);GO:0048661(positive regulation of smooth muscle cell proliferation);GO:0050729(positive regulation of inflammatory response);GO:0051260(protein homooligomerization);GO:0051482(elevation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway);GO:0051561(elevation of mitochondrial calcium ion concentration);GO:0060445(branching involved in salivary gland morphogenesis);GO:0060662(salivary gland cavitation);GO:0070062(extracellular vesicular exosome) | 05016(Huntington's disease) |
A_19_P00811706 | 8.10 | 8.51 | 8.18 | 6.82 | 6.48 | 6.62 | 1.24 | 0.32 | up | 0.00 | yes | ref|NM_005578|ref|NM_001167671|ref|NM_001167672|ens|ENST00000616304 | 4026 | LPP | LIM domain containing preferred translocation partner in lipoma | Homo sapiens LIM domain containing preferred translocation partner in lipoma (LPP), transcript variant 1, mRNA [NM_005578] | chr3 | 188601619 | 188601678 | GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0007155(cell adhesion);GO:0008150(biological_process);GO:0008270(zinc ion binding) | |
A_32_P135336 | 6.82 | 6.82 | 6.75 | 7.46 | 7.55 | 7.34 | 0.91 | -0.13 | down | 0.00 | yes | ref|NR_002556|ref|NR_002557|ref|XM_006726617|tc|THC2546736 | 388242 | LOC388242 | coiled-coil domain containing 101 pseudogene | Homo sapiens coiled-coil domain containing 101 pseudogene (LOC388242), non-coding RNA [NR_002556] | chr16 | 29476353 | 29476294 | ||
A_22_P00016477 | 8.03 | 8.29 | 8.16 | 7.41 | 7.33 | 7.31 | 1.11 | 0.15 | up | 0.00 | yes | linc|lnc-TMEM86A-1:1|tc|THC2607151 | lnc-TMEM86A-1 | lnc-TMEM86A-1:1 | HSU27831 striatum-enriched phosphatase {Homo sapiens} (exp=-1; wgp=0; cg=0), partial (5%) [THC2607151] | chr11 | 18762025 | 18762084 | |||
A_19_P00812701 | 7.04 | 7.20 | 6.75 | 8.48 | 8.80 | 8.57 | 0.81 | -0.30 | down | 0.00 | yes | chr6 | 5041726 | 5041785 | |||||||
A_33_P3317825 | 12.87 | 12.68 | 12.86 | 13.42 | 13.43 | 13.48 | 0.95 | -0.07 | down | 0.00 | yes | ref|NM_002524|ens|ENST00000369535|gb|AF493919|gb|BT019734 | 4893 | NRAS | neuroblastoma RAS viral (v-ras) oncogene homolog | Homo sapiens neuroblastoma RAS viral (v-ras) oncogene homolog (NRAS), mRNA [NM_002524] | chr1 | 115251224 | 115251165 | GO:0000139(Golgi membrane);GO:0000165(MAPK cascade);GO:0000186(activation of MAPKK activity);GO:0005525(GTP binding);GO:0005886(plasma membrane);GO:0006184(GTP catabolic process);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007264(small GTPase mediated signal transduction);GO:0007265(Ras protein signal transduction);GO:0007411(axon guidance);GO:0007596(blood coagulation);GO:0008284(positive regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0008542(visual learning);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0016020(membrane);GO:0030036(actin cytoskeleton organization);GO:0032228(regulation of synaptic transmission, GABAergic);GO:0032403(protein complex binding);GO:0035022(positive regulation of Rac protein signal transduction);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0043524(negative regulation of neuron apoptotic process);GO:0045087(innate immune response);GO:0045596(negative regulation of cell differentiation);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0048011(nerve growth factor receptor signaling pathway);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048642(negative regulation of skeletal muscle tissue development);GO:0050900(leukocyte migration);GO:0051146(striated muscle cell differentiation);GO:0060441(epithelial tube branching involved in lung morphogenesis);GO:0070062(extracellular vesicular exosome) | 04014(Ras signaling pathway|04015:Rap1 signaling pathway|04010:MAPK signaling pathway|04012:ErbB signaling pathway|04370:VEGF signaling pathway|04068:FoxO signaling pathway|04071:Sphingolipid signaling pathway|04151:PI3K-Akt signaling pathway|04810:Regulation of actin cytoskeleton|04530:Tight junction|04540:Gap junction|04550:Signaling pathways regulating pluripotency of stem cells|04650:Natural killer cell mediated cytotoxicity|04660:T cell receptor signaling pathway|04662:B cell receptor signaling pathway|04664:Fc epsilon RI signaling pathway|04062:Chemokine signaling pathway|04910:Insulin signaling pathway|04912:GnRH signaling pathway|04915:Estrogen signaling pathway|04917:Prolactin signaling pathway|04921:Oxytocin signaling pathway|04919:Thyroid hormone signaling pathway|04916:Melanogenesis|04725:Cholinergic synapse|04726:Serotonergic synapse|04720:Long-term potentiation|04730:Long-term depression|04722:Neurotrophin signaling pathway|04360:Axon guidance|05200:Pathways in cancer|05230:Central carbon metabolism in cancer|05231:Choline metabolism in cancer|05206:MicroRNAs in cancer|05205:Proteoglycans in cancer|05203:Viral carcinogenesis|05214:Glioma|05216:Thyroid cancer|05221:Acute myeloid leukemia|05220:Chronic myeloid leukemia|05218:Melanoma|05211:Renal cell carcinoma|05219:Bladder cancer|05215:Prostate cancer|05213:Endometrial cancer|05223:Non-small cell lung cancer|05034:Alcoholism|05166:HTLV-I infection|05161:Hepatitis B|05160:Hepatitis C) |
A_33_P3407937 | 10.74 | 10.68 | 10.86 | 11.28 | 11.32 | 11.29 | 0.95 | -0.07 | down | 0.00 | yes | ref|NM_018390|ref|NR_028057|ens|ENST00000381663|ens|ENST00000399012 | 55344 | PLCXD1 | phosphatidylinositol-specific phospholipase C, X domain containing 1 | Homo sapiens phosphatidylinositol-specific phospholipase C, X domain containing 1 (PLCXD1), transcript variant 1, mRNA [NM_018390] | chrX | 208260 | 208319 | GO:0006629(lipid metabolic process);GO:0008081(phosphoric diester hydrolase activity) | |
A_24_P398064 | 12.45 | 12.56 | 12.60 | 12.09 | 12.05 | 12.02 | 1.04 | 0.06 | up | 0.00 | yes | ens|ENST00000378078|gb|D87447|tc|THC2514920 | 9827 | RGP1 | RGP1 retrograde golgi transport homolog (S. cerevisiae) | RGP1 retrograde golgi transport homolog (S. cerevisiae) [Source:HGNC Symbol;Acc:HGNC:21965] [ENST00000378078] | chr9 | 35757656 | 35757715 | GO:0005515(protein binding);GO:0005829(cytosol);GO:0016020(membrane);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017137(Rab GTPase binding);GO:0032851(positive regulation of Rab GTPase activity);GO:0034066(Ric1p-Rgp1p complex);GO:0042147(retrograde transport, endosome to Golgi);GO:0043234(protein complex) | |
A_32_P18250 | 13.60 | 13.60 | 13.67 | 13.13 | 13 | 13.16 | 1.04 | 0.06 | up | 0.00 | yes | ref|NR_003663|ens|ENST00000443452|ens|ENST00000331369|gb|BC040550 | 388965 | FUNDC2P2 | FUN14 domain containing 2 pseudogene 2 | Homo sapiens FUN14 domain containing 2 pseudogene 2 (FUNDC2P2), non-coding RNA [NR_003663] | chr2 | 84518284 | 84518343 | ||
A_33_P3415430 | 13.10 | 13.08 | 13.26 | 13.78 | 13.81 | 13.71 | 0.95 | -0.07 | down | 0.00 | yes | ref|NM_005346|ens|ENST00000545241|ens|ENST00000391548|ens|ENST00000375650 | 3304 | HSPA1B | heat shock 70kDa protein 1B | Homo sapiens heat shock 70kDa protein 1B (HSPA1B), mRNA [NM_005346] | chr6 | 31797870 | 31797929 | GO:0000151(ubiquitin ligase complex);GO:0001618(viral receptor activity);GO:0001664(G-protein coupled receptor binding);GO:0003725(double-stranded RNA binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005783(endoplasmic reticulum);GO:0005814(centriole);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0006200(ATP catabolic process);GO:0006402(mRNA catabolic process);GO:0006986(response to unfolded protein);GO:0008180(signalosome);GO:0008285(negative regulation of cell proliferation);GO:0009615(response to virus);GO:0010467(gene expression);GO:0010941(regulation of cell death);GO:0016234(inclusion body);GO:0016235(aggresome);GO:0016607(nuclear speck);GO:0016887(ATPase activity);GO:0019899(enzyme binding);GO:0030308(negative regulation of cell growth);GO:0030529(ribonucleoprotein complex);GO:0031072(heat shock protein binding);GO:0031397(negative regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0031982(vesicle);GO:0034599(cellular response to oxidative stress);GO:0034605(cellular response to heat);GO:0042026(protein refolding);GO:0042623(ATPase activity, coupled);GO:0043066(negative regulation of apoptotic process);GO:0044183(protein binding involved in protein folding);GO:0045648(positive regulation of erythrocyte differentiation);GO:0047485(protein N-terminus binding);GO:0048471(perinuclear region of cytoplasm);GO:0050821(protein stabilization);GO:0051082(unfolded protein binding);GO:0060548(negative regulation of cell death);GO:0070062(extracellular vesicular exosome);GO:0070370(cellular heat acclimation);GO:0072562(blood microparticle);GO:0090084(negative regulation of inclusion body assembly);GO:1900034(regulation of cellular response to heat);GO:2001240(negative regulation of extrinsic apoptotic signaling pathway in absence of ligand) | 03040(Spliceosome|04141:Protein processing in endoplasmic reticulum|04010:MAPK signaling pathway|04144:Endocytosis|04612:Antigen processing and presentation|04915:Estrogen signaling pathway|05134:Legionellosis|05162:Measles|05164:Influenza A|05169:Epstein-Barr virus infection|05145:Toxoplasmosis) |
A_22_P00015379 | 8.92 | 8.86 | 8.68 | 9.84 | 9.82 | 9.63 | 0.90 | -0.15 | down | 0.00 | yes | ref|XR_424822|ref|XR_429964|ref|XR_430800|ref|XR_433386 | 101929494 | LOC101929494 | uncharacterized LOC101929494 | PREDICTED: Homo sapiens uncharacterized LOC101929494 (LOC101929494), transcript variant X3, ncRNA [XR_424822] | chr17 | 36607637 | 36607578 | ||
A_23_P56228 | 10.68 | 11.02 | 10.88 | 11.92 | 11.79 | 11.85 | 0.92 | -0.13 | down | 0.00 | yes | ref|NM_016573|ref|NM_001288999|ref|NM_001288998|ens|ENST00000203556 | 51291 | GMIP | GEM interacting protein | Homo sapiens GEM interacting protein (GMIP), transcript variant 1, mRNA [NM_016573] | chr19 | 19740535 | 19740476 | GO:0005100(Rho GTPase activator activity);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005829(cytosol);GO:0007264(small GTPase mediated signal transduction);GO:0032321(positive regulation of Rho GTPase activity);GO:0034259(negative regulation of Rho GTPase activity);GO:0035556(intracellular signal transduction);GO:0046872(metal ion binding);GO:0051056(regulation of small GTPase mediated signal transduction) | |
A_21_P0008233 | 9.78 | 9.62 | 9.70 | 10.34 | 10.21 | 10.35 | 0.94 | -0.09 | down | 0.00 | yes | linc|lnc-PABPC3-1:2|linc|lnc-PABPC3-1:1|linc|TCONS_00022147|linc|TCONS_00021734 | lnc-PABPC3-1 | lnc-PABPC3-1:2 | LNCipedia lincRNA (lnc-PABPC3-1), lincRNA [lnc-PABPC3-1:2] | chr13 | 25692991 | 25693050 | |||
A_23_P360754 | 8.18 | 8.63 | 8.56 | 5.85 | 6.31 | 5.48 | 1.44 | 0.52 | up | 0.00 | yes | ref|NM_005099|gb|AB014588|gb|BC063293|gb|AY358886 | 9507 | ADAMTS4 | ADAM metallopeptidase with thrombospondin type 1 motif, 4 | Homo sapiens ADAM metallopeptidase with thrombospondin type 1 motif, 4 (ADAMTS4), mRNA [NM_005099] | chr1 | 161159705 | 161159646 | GO:0001501(skeletal system development);GO:0002020(protease binding);GO:0004222(metalloendopeptidase activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0022617(extracellular matrix disassembly);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0042742(defense response to bacterium) | |
A_33_P3336760 | 9.91 | 9.50 | 9.80 | 8.27 | 8.47 | 8.51 | 1.16 | 0.21 | up | 0.00 | yes | ref|NM_018849|ref|NM_000443|ref|NM_018850|ens|ENST00000265723 | 5244 | ABCB4 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 | Homo sapiens ATP-binding cassette, sub-family B (MDR/TAP), member 4 (ABCB4), transcript variant B, mRNA [NM_018849] | chr7 | 87031442 | 87031383 | GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006629(lipid metabolic process);GO:0006810(transport);GO:0006855(drug transmembrane transport);GO:0008559(xenobiotic-transporting ATPase activity);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0042493(response to drug);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0042908(xenobiotic transport);GO:0044255(cellular lipid metabolic process);GO:0044281(small molecule metabolic process);GO:0046581(intercellular canaliculus);GO:0055085(transmembrane transport);GO:0070062(extracellular vesicular exosome) | 02010(ABC transporters|04976:Bile secretion) |
A_23_P250136 | 7.48 | 6.83 | 7.52 | 4.33 | 3.94 | 3.31 | 1.89 | 0.91 | up | 0.00 | yes | ref|NM_175768|ref|NM_001166247|ref|NM_021956|ens|ENST00000369138 | 2898 | GRIK2 | glutamate receptor, ionotropic, kainate 2 | Homo sapiens glutamate receptor, ionotropic, kainate 2 (GRIK2), transcript variant 2, mRNA [NM_175768] | chr6 | 102516621 | 102516680 | GO:0001662(behavioral fear response);GO:0005234(extracellular-glutamate-gated ion channel activity);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006810(transport);GO:0006874(cellular calcium ion homeostasis);GO:0006886(intracellular protein transport);GO:0007215(glutamate receptor signaling pathway);GO:0007268(synaptic transmission);GO:0014069(postsynaptic density);GO:0015277(kainate selective glutamate receptor activity);GO:0019228(regulation of action potential in neuron);GO:0030054(cell junction);GO:0030165(PDZ domain binding);GO:0030425(dendrite);GO:0031624(ubiquitin conjugating enzyme binding);GO:0031625(ubiquitin protein ligase binding);GO:0032839(dendrite cytoplasm);GO:0032983(kainate selective glutamate receptor complex);GO:0034220(ion transmembrane transport);GO:0035235(ionotropic glutamate receptor signaling pathway);GO:0035249(synaptic transmission, glutamatergic);GO:0042734(presynaptic membrane);GO:0042803(protein homodimerization activity);GO:0043113(receptor clustering);GO:0043195(terminal button);GO:0043204(perikaryon);GO:0043524(negative regulation of neuron apoptotic process);GO:0043525(positive regulation of neuron apoptotic process);GO:0045211(postsynaptic membrane);GO:0046328(regulation of JNK cascade);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0050804(regulation of synaptic transmission);GO:0050806(positive regulation of synaptic transmission);GO:0051402(neuron apoptotic process);GO:0051967(negative regulation of synaptic transmission, glutamatergic);GO:0060079(regulation of excitatory postsynaptic membrane potential);GO:0060080(regulation of inhibitory postsynaptic membrane potential) | 04080(Neuroactive ligand-receptor interaction|04724:Glutamatergic synapse) |
A_22_P00014149 | 7.44 | 7.10 | 7.01 | 9.12 | 8.66 | 9.02 | 0.80 | -0.31 | down | 0.00 | yes | ens|ENST00000577329|linc|lnc-SCN4A-1:1 | chr17 | 62050545 | 62050486 | ||||||
A_33_P3418025 | 9.33 | 9.24 | 9.62 | 7.79 | 8.08 | 8.12 | 1.18 | 0.23 | up | 0.00 | yes | ref|NM_001334|ens|ENST00000433477|ens|ENST00000573499|gb|BC049206 | 1519 | CTSO | cathepsin O | Homo sapiens cathepsin O (CTSO), mRNA [NM_001334] | chr4 | 156845446 | 156845387 | GO:0004197(cysteine-type endopeptidase activity);GO:0005764(lysosome);GO:0006508(proteolysis) | 04142(Lysosome) |
A_33_P3764744 | 9.65 | 9.04 | 9.21 | 11.37 | 11.18 | 11.01 | 0.83 | -0.27 | down | 0.00 | yes | tc|THC2596880 | HSU02032 ribosomal protein L23a {Homo sapiens} (exp=-1; wgp=0; cg=0), partial (70%) [THC2596880] | chr17 | 59148235 | 59148294 | GO:0003723(RNA binding);GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0006412(translation) | ||||
A_21_P0004977 | 10.53 | 10.49 | 10.58 | 11.07 | 10.96 | 11.14 | 0.95 | -0.07 | down | 0.00 | yes | linc|lnc-FAM120B-6:2|linc|TCONS_00012028 | lnc-FAM120B-6 | lnc-FAM120B-6:2 | LNCipedia lincRNA (lnc-FAM120B-6), lincRNA [lnc-FAM120B-6:2] | chr6 | 170455160 | 170455219 | |||
A_23_P65129 | 10.99 | 10.65 | 10.78 | 11.84 | 11.70 | 11.75 | 0.92 | -0.12 | down | 0.00 | yes | ref|NM_032840|ens|ENST00000301463|gb|BC136312|gb|AK027706 | 84926 | SPRYD3 | SPRY domain containing 3 | Homo sapiens SPRY domain containing 3 (SPRYD3), mRNA [NM_032840] | chr12 | 53458705 | 53458646 | ||
A_24_P309645 | 12.52 | 12.46 | 12.51 | 11.44 | 11.78 | 11.59 | 1.08 | 0.11 | up | 0.00 | yes | ref|NM_017901|ref|NM_001143819|ref|NM_001301214|ens|ENST00000551127 | 53373 | TPCN1 | two pore segment channel 1 | Homo sapiens two pore segment channel 1 (TPCN1), transcript variant 2, mRNA [NM_017901] | chr12 | 113730870 | 113731124 | GO:0005245(voltage-gated calcium channel activity);GO:0005515(protein binding);GO:0005765(lysosomal membrane);GO:0005886(plasma membrane);GO:0006816(calcium ion transport);GO:0010008(endosome membrane);GO:0016021(integral to membrane);GO:0034220(ion transmembrane transport);GO:0034765(regulation of ion transmembrane transport);GO:0042802(identical protein binding);GO:0055085(transmembrane transport);GO:0070588(calcium ion transmembrane transport);GO:0072345(NAADP-sensitive calcium-release channel activity);GO:0086010(membrane depolarization involved in regulation of action potential) | |
A_22_P00005067 | 5.80 | 5.50 | 5.68 | 4.67 | 4.46 | 4.33 | 1.26 | 0.34 | up | 0.00 | yes | ens|ENST00000545293|ens|ENST00000543611|linc|lnc-DENR-2:2|linc|lnc-DENR-2:1 | chr12 | 123200160 | 123200219 | ||||||
A_23_P169112 | 11.77 | 11.51 | 11.52 | 12.47 | 12.58 | 12.72 | 0.92 | -0.12 | down | 0.00 | yes | ref|NM_013291|ens|ENST00000526271|ens|ENST00000620219|ens|ENST00000616140 | 29894 | CPSF1 | cleavage and polyadenylation specific factor 1, 160kDa | Homo sapiens cleavage and polyadenylation specific factor 1, 160kDa (CPSF1), mRNA [NM_013291] | chr8 | 145619722 | 145619663 | GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0003730(mRNA 3'-UTR binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005847(mRNA cleavage and polyadenylation specificity factor complex);GO:0006366(transcription from RNA polymerase II promoter);GO:0006369(termination of RNA polymerase II transcription);GO:0006378(mRNA polyadenylation);GO:0006379(mRNA cleavage);GO:0006406(mRNA export from nucleus);GO:0008380(RNA splicing);GO:0010467(gene expression);GO:0031124(mRNA 3'-end processing) | 03015(mRNA surveillance pathway) |
A_23_P46039 | 7.66 | 6.72 | 8.10 | 3.88 | 3.32 | 3.22 | 2.16 | 1.11 | up | 0.00 | yes | ref|NM_032738|ref|NM_001184866|ref|NM_001184867|ref|NM_001184870 | 84824 | FCRLA | Fc receptor-like A | Homo sapiens Fc receptor-like A (FCRLA), transcript variant 2, mRNA [NM_032738] | chr1 | 161683792 | 161683851 | GO:0005576(extracellular region);GO:0005737(cytoplasm);GO:0030154(cell differentiation) | |
A_22_P00007531 | 12.15 | 12.09 | 12.15 | 11.78 | 11.63 | 11.66 | 1.04 | 0.05 | up | 0.00 | yes | ref|NR_029373|ref|NR_029374|linc|lnc-HADH-1:3|linc|lnc-HADH-1:1 | 641518 | LEF1-AS1 | LEF1 antisense RNA 1 | Homo sapiens LEF1 antisense RNA 1 (LEF1-AS1), transcript variant 1, long non-coding RNA [NR_029373] | chr4 | 109097484 | 109097543 | ||
A_33_P3341442 | 10.33 | 10.10 | 9.98 | 11.32 | 11.23 | 11.09 | 0.90 | -0.15 | down | 0.00 | yes | ref|NM_000395|ens|ENST00000262825|ens|ENST00000403662|ref|XM_005261340 | 1439 | CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | Homo sapiens colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) (CSF2RB), mRNA [NM_000395] | chr22 | 37334388 | 37334447 | GO:0004872(receptor activity);GO:0004912(interleukin-3 receptor activity);GO:0004914(interleukin-5 receptor activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0007165(signal transduction);GO:0007585(respiratory gaseous exchange);GO:0030526(granulocyte macrophage colony-stimulating factor receptor complex);GO:0032496(response to lipopolysaccharide);GO:0036016(cellular response to interleukin-3);GO:0038043(interleukin-5-mediated signaling pathway);GO:0038156(interleukin-3-mediated signaling pathway) | 04630(Jak-STAT signaling pathway|04060:Cytokine-cytokine receptor interaction|04210:Apoptosis) |
A_24_P265088 | 10.04 | 10.08 | 10.27 | 9.44 | 9.26 | 9.27 | 1.09 | 0.12 | up | 0.00 | yes | ens|ENST00000393758|ens|ENST00000544474|ens|ENST00000164640|gb|AK127016 | 57595 | PDZD4 | PDZ domain containing 4 | PDZ domain containing 4 [Source:HGNC Symbol;Acc:HGNC:21167] [ENST00000393758] | chrX | 153068362 | 153068303 | GO:0005938(cell cortex) | |
A_33_P3374559 | 10.93 | 11.14 | 10.89 | 12.21 | 12.18 | 12.59 | 0.89 | -0.17 | down | 0.00 | yes | ref|NR_024448|ens|ENST00000444220|ens|ENST00000437294|ens|ENST00000435868 | 91316 | GUSBP11 | glucuronidase, beta pseudogene 11 | Homo sapiens glucuronidase, beta pseudogene 11 (GUSBP11), non-coding RNA [NR_024448] | chr22 | 24057258 | 24057199 | ||
A_33_P3316728 | 7.26 | 7.31 | 7.31 | 7.64 | 7.65 | 7.77 | 0.95 | -0.08 | down | 0.00 | yes | ens|ENST00000567850|ens|ENST00000564895 | DNM1 pseudogene 34 [Source:HGNC Symbol;Acc:HGNC:35181] [ENST00000567850] | chr15 | 75594935 | 75594876 | |||||
A_24_P333663 | 12.54 | 12.51 | 12.85 | 11.46 | 11.12 | 11.39 | 1.12 | 0.16 | up | 0.00 | yes | ref|NM_002748|ens|ENST00000518703|ens|ENST00000403865|ref|XM_005254536 | 5597 | MAPK6 | mitogen-activated protein kinase 6 | Homo sapiens mitogen-activated protein kinase 6 (MAPK6), mRNA [NM_002748] | chr15 | 52356907 | 52356966 | GO:0000165(MAPK cascade);GO:0004674(protein serine/threonine kinase activity);GO:0004707(MAP kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0019901(protein kinase binding);GO:0046982(protein heterodimerization activity) | |
A_22_P00018902 | 11.21 | 11.46 | 11.35 | 10.36 | 10.57 | 10.54 | 1.08 | 0.11 | up | 0.00 | yes | linc|lnc-C11orf39-3:1|gb|DA375949 | lnc-C11orf39-3 | lnc-C11orf39-3:1 | DA375949 BRTHA2 Homo sapiens cDNA clone BRTHA2007423 5', mRNA sequence [DA375949] | chr11 | 131747657 | 131747598 | |||
A_21_P0008490 | 10.97 | 11.82 | 10.76 | 14.57 | 14.55 | 14.03 | 0.78 | -0.36 | down | 0.00 | yes | linc|lnc-RTL1-6:1|linc|TCONS_00022880 | lnc-RTL1-6 | lnc-RTL1-6:1 | LNCipedia lincRNA (lnc-RTL1-6), lincRNA [lnc-RTL1-6:1] | chr14 | 101820284 | 101820225 | |||
A_33_P3226377 | 11.72 | 11.89 | 11.76 | 11.35 | 11.28 | 11.30 | 1.04 | 0.06 | up | 0.00 | yes | ref|NM_005042|ref|NM_001110213|ens|ENST00000381847|ens|ENST00000575657 | 5555 | PRH2 | proline-rich protein HaeIII subfamily 2 | Homo sapiens proline-rich protein HaeIII subfamily 2 (PRH2), transcript variant 1, mRNA [NM_005042] | chr12 | 11083624 | 11083683 | GO:0005515(protein binding);GO:0005615(extracellular space) | 04970(Salivary secretion) |
A_33_P3257568 | 7.07 | 6.97 | 6.72 | 7.87 | 7.95 | 7.82 | 0.88 | -0.19 | down | 0.00 | yes | ens|ENST00000373851|gb|AK097636|tc|THC2721284 | 11064 | CNTRL | centriolin | centriolin [Source:HGNC Symbol;Acc:HGNC:1858] [ENST00000373851] | chr9 | 123912863 | 123912922 | GO:0000086(G2/M transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006996(organelle organization);GO:0016020(membrane);GO:0051301(cell division) | |
A_22_P00011020 | 10.81 | 10.80 | 10.71 | 11.51 | 11.54 | 11.31 | 0.94 | -0.09 | down | 0.00 | yes | linc|lnc-NT5C-2:1 | lnc-NT5C-2 | lnc-NT5C-2:1 | LNCipedia lincRNA (lnc-NT5C-2), lincRNA [lnc-NT5C-2:1] | chr17 | 73141416 | 73141357 | |||
A_33_P3346403 | 17.59 | 17.59 | 17.48 | 17.89 | 17.92 | 17.97 | 0.98 | -0.03 | down | 0.00 | yes | ref|NM_001099285|ref|NM_002823|ens|ENST00000397729|ens|ENST00000393073 | 5757 | PTMA | prothymosin, alpha | Homo sapiens prothymosin, alpha (PTMA), transcript variant 1, mRNA [NM_001099285] | chr2 | 232577214 | 232577560 | GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0070062(extracellular vesicular exosome) | 05169(Epstein-Barr virus infection) |
A_33_P3266646 | 8.38 | 8.50 | 8.52 | 9.07 | 9.01 | 9.21 | 0.93 | -0.10 | down | 0.00 | yes | ref|NM_138813|ref|NM_001178002|ref|NR_047593|ens|ENST00000533107 | 148229 | ATP8B3 | ATPase, aminophospholipid transporter, class I, type 8B, member 3 | Homo sapiens ATPase, aminophospholipid transporter, class I, type 8B, member 3 (ATP8B3), transcript variant 1, mRNA [NM_138813] | chr19 | 1800003 | 1797004 | GO:0000287(magnesium ion binding);GO:0002080(acrosomal membrane);GO:0004012(phospholipid-translocating ATPase activity);GO:0005524(ATP binding);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0007030(Golgi organization);GO:0007339(binding of sperm to zona pellucida);GO:0008152(metabolic process);GO:0016021(integral to membrane);GO:0045332(phospholipid translocation) | |
A_23_P104689 | 11.77 | 11.67 | 11.65 | 11.21 | 11.32 | 11.29 | 1.04 | 0.05 | up | 0.00 | yes | ref|NM_021975|ref|NM_001145138|ref|NM_001243984|ref|NM_001243985 | 5970 | RELA | v-rel avian reticuloendotheliosis viral oncogene homolog A | Homo sapiens v-rel avian reticuloendotheliosis viral oncogene homolog A (RELA), transcript variant 1, mRNA [NM_021975] | chr11 | 65421710 | 65421651 | GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0001077(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0001078(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription);GO:0001205(RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0001889(liver development);GO:0001942(hair follicle development);GO:0002224(toll-like receptor signaling pathway);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0002756(MyD88-independent toll-like receptor signaling pathway);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003705(RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006117(acetaldehyde metabolic process);GO:0006366(transcription from RNA polymerase II promoter);GO:0006954(inflammatory response);GO:0006968(cellular defense response);GO:0007568(aging);GO:0008134(transcription factor binding);GO:0008284(positive regulation of cell proliferation);GO:0009612(response to mechanical stimulus);GO:0009887(organ morphogenesis);GO:0010033(response to organic substance);GO:0010224(response to UV-B);GO:0014040(positive regulation of Schwann cell differentiation);GO:0016032(viral reproduction);GO:0019221(cytokine-mediated signaling pathway);GO:0019901(protein kinase binding);GO:0031293(membrane protein intracellular domain proteolysis);GO:0031625(ubiquitin protein ligase binding);GO:0032332(positive regulation of chondrocyte differentiation);GO:0032403(protein complex binding);GO:0032481(positive regulation of type I interferon production);GO:0032495(response to muramyl dipeptide);GO:0032570(response to progesterone stimulus);GO:0032868(response to insulin stimulus);GO:0033256(I-kappaB/NF-kappaB complex);GO:0033590(response to cobalamin);GO:0033613(activating transcription factor binding);GO:0034134(toll-like receptor 2 signaling pathway);GO:0034138(toll-like receptor 3 signaling pathway);GO:0034142(toll-like receptor 4 signaling pathway);GO:0034146(toll-like receptor 5 signaling pathway);GO:0034162(toll-like receptor 9 signaling pathway);GO:0034166(toll-like receptor 10 signaling pathway);GO:0035666(TRIF-dependent toll-like receptor signaling pathway);GO:0038061(NIK/NF-kappaB cascade);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0038123(toll-like receptor TLR1:TLR2 signaling pathway);GO:0038124(toll-like receptor TLR6:TLR2 signaling pathway) | 04014(Ras signaling pathway|04010:MAPK signaling pathway|04064:NF-kappa B signaling pathway|04668:TNF signaling pathway|04066:HIF-1 signaling pathway|04071:Sphingolipid signaling pathway|04024:cAMP signaling pathway|04151:PI3K-Akt signaling pathway|04210:Apoptosis|04620:Toll-like receptor signaling pathway|04621:NOD-like receptor signaling pathway|04622:RIG-I-like receptor signaling pathway|04623:Cytosolic DNA-sensing pathway|04660:T cell receptor signaling pathway|04662:B cell receptor signaling pathway|04062:Chemokine signaling pathway|04920:Adipocytokine signaling pathway|04917:Prolactin signaling pathway|04722:Neurotrophin signaling pathway|04380:Osteoclast differentiation|05200:Pathways in cancer|05202:Transcriptional misregulation in cancers|05203:Viral carcinogenesis|05212:Pancreatic cancer|05221:Acute myeloid leukemia|05220:Chronic myeloid leukemia|05215:Prostate cancer|05222:Small cell lung cancer|05321:Inflammatiory bowel disease (IBD)|05030:Cocaine addiction|04932:Non-alcoholic fatty liver disease (NAFLD)|05120:Epithelial cell signaling in Helicobacter pylori infection|05132:Salmonella infection|05131:Shigellosis|05133:Pertussis|05134:Legionellosis|05152:Tuberculosis|05166:HTLV-I infection|05162:Measles|05164:Influenza A|05161:Hepatitis B|05160:Hepatitis C|05168:Herpes simplex infection|05169:Epstein-Barr virus infection|05146:Amoebiasis|05145:Toxoplasmosis|05140:Leishmaniasis|05142:Chagas disease (American trypanosomiasis)) |
A_32_P160896 | 14.12 | 14.55 | 14.36 | 11.32 | 12.05 | 10.98 | 1.25 | 0.33 | up | 0.00 | yes | ref|NM_177478|ens|ENST00000321339|gb|HQ258558|gb|BC034419 | 94033 | FTMT | ferritin mitochondrial | Homo sapiens ferritin mitochondrial (FTMT), mRNA [NM_177478] | chr5 | 121188259 | 121188318 | GO:0004322(ferroxidase activity);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0008199(ferric iron binding);GO:0008284(positive regulation of cell proliferation);GO:0051347(positive regulation of transferase activity);GO:0051349(positive regulation of lyase activity);GO:0051353(positive regulation of oxidoreductase activity);GO:0055114(oxidation-reduction process) | |
A_21_P0001177 | 11.71 | 11.56 | 12.27 | 9.79 | 9.59 | 9.23 | 1.24 | 0.31 | up | 0.00 | yes | linc|lnc-FAM72C-2:1|ref|XM_006711090|ref|XM_006726339|linc|TCONS_00000639 | lnc-FAM72C-2 | lnc-FAM72C-2:1 | PREDICTED: Homo sapiens myomegalin-like (LOC100996723), mRNA [XM_006711090] | chr1 | 144506631 | 144506690 | |||
A_33_P3257714 | 10.65 | 10.72 | 10.92 | 9.83 | 10.01 | 9.97 | 1.08 | 0.12 | up | 0.00 | yes | ref|NM_001025|ens|ENST00000296674|gb|M32219|gb|BX647563 | 6228 | RPS23 | ribosomal protein S23 | Homo sapiens ribosomal protein S23 (RPS23), mRNA [NM_001025] | chr5 | 81569349 | 81569290 | GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005840(ribosome);GO:0006412(translation);GO:0006413(translational initiation);GO:0006414(translational elongation);GO:0006415(translational termination);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0010467(gene expression);GO:0016020(membrane);GO:0016032(viral reproduction);GO:0019058(viral infectious cycle);GO:0019083(viral transcription);GO:0022627(cytosolic small ribosomal subunit);GO:0044267(cellular protein metabolic process) | 03010(Ribosome) |
A_33_P3394395 | 10.82 | 11.09 | 11.26 | 9.80 | 9.62 | 9.90 | 1.13 | 0.18 | up | 0.00 | yes | ref|NM_001270384|ref|NM_198549|ens|ENST00000370791|ens|ENST00000443751 | 374986 | FAM73A | family with sequence similarity 73, member A | Homo sapiens family with sequence similarity 73, member A (FAM73A), transcript variant 2, mRNA [NM_001270384] | chr1 | 78343754 | 78343813 | GO:0016021(integral to membrane) | |
A_22_P00012557 | 7.73 | 7.98 | 7.92 | 7.14 | 7.17 | 7.25 | 1.10 | 0.13 | up | 0.00 | yes | ref|NR_033374|linc|lnc-PTGES2-1:4|linc|lnc-PTGES2-1:1|linc|lnc-PTGES2-1:5 | 100289019 | SLC25A25-AS1 | SLC25A25 antisense RNA 1 | Homo sapiens SLC25A25 antisense RNA 1 (SLC25A25-AS1), long non-coding RNA [NR_033374] | chr9 | 130876872 | 130876813 | ||
A_19_P00322898 | 12.23 | 12.23 | 12.21 | 11.98 | 11.99 | 11.89 | 1.02 | 0.03 | up | 0.00 | yes | ref|NR_026551|ens|ENST00000448692|ens|ENST00000380333|tc|THC2501410 | 340591 | CA5BP1 | carbonic anhydrase VB pseudogene 1 | Homo sapiens carbonic anhydrase VB pseudogene 1 (CA5BP1), non-coding RNA [NR_026551] | chrX | 15693842 | 15693901 | GO:0004089(carbonate dehydratase activity);GO:0005739(mitochondrion);GO:0008152(metabolic process);GO:0008270(zinc ion binding) | |
A_23_P57868 | 11.50 | 11.31 | 11.25 | 12.28 | 12.57 | 12.67 | 0.91 | -0.14 | down | 0.00 | yes | ref|NM_000666|ref|NM_001198895|ref|NM_001198898|ref|NM_001198897 | 95 | ACY1 | aminoacylase 1 | Homo sapiens aminoacylase 1 (ACY1), transcript variant 1, mRNA [NM_000666] | chr3 | 52022979 | 52023038 | GO:0004046(aminoacylase activity);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0006520(cellular amino acid metabolic process);GO:0006805(xenobiotic metabolic process);GO:0008237(metallopeptidase activity);GO:0044281(small molecule metabolic process);GO:0046872(metal ion binding);GO:0070062(extracellular vesicular exosome) | 01210(2-Oxocarboxylic acid metabolism|01230:Biosynthesis of amino acids|00330:Arginine and proline metabolism) |
A_23_P149494 | 12.37 | 11.98 | 12.46 | 11.02 | 10.89 | 11.05 | 1.12 | 0.16 | up | 0.00 | yes | ref|NM_015600|ref|NM_001042472|ens|ENST00000481556|ens|ENST00000376542 | 26090 | ABHD12 | abhydrolase domain containing 12 | Homo sapiens abhydrolase domain containing 12 (ABHD12), transcript variant 2, mRNA [NM_015600] | chr20 | 25288665 | 25288606 | GO:0006660(phosphatidylserine catabolic process);GO:0007628(adult walking behavior);GO:0010996(response to auditory stimulus);GO:0032281(alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex);GO:0047372(acylglycerol lipase activity) | |
A_24_P212129 | 10.94 | 10.94 | 11.02 | 11.45 | 11.64 | 11.68 | 0.95 | -0.08 | down | 0.00 | yes | ref|NM_006974|ref|NM_001278170|ref|NM_001278173|ref|NM_001278178 | 7581 | ZNF33A | zinc finger protein 33A | Homo sapiens zinc finger protein 33A (ZNF33A), transcript variant 2, mRNA [NM_006974] | chr10 | 38306221 | 38306280 | GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding) | |
A_32_P221799 | 11.41 | 11.46 | 11.05 | 13 | 12.58 | 12.98 | 0.88 | -0.18 | down | 0.00 | yes | ref|NM_003514|gb|BC071668|gb|BC032686|gb|BC032756 | 8336 | HIST1H2AM | histone cluster 1, H2am | Homo sapiens histone cluster 1, H2am (HIST1H2AM), mRNA [NM_003514] | chr6 | 27860566 | 27860507 | GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0008150(biological_process);GO:0019899(enzyme binding);GO:0046982(protein heterodimerization activity);GO:0070062(extracellular vesicular exosome) | 05322(Systemic lupus erythematosus|05034:Alcoholism) |
A_33_P3353030 | 10.98 | 10.88 | 11.11 | 10.30 | 10.04 | 10.10 | 1.08 | 0.12 | up | 0.00 | yes | ref|NM_003353|ens|ENST00000296099|tc|THC2476757 | 7349 | UCN | urocortin | Homo sapiens urocortin (UCN), mRNA [NM_003353] | chr2 | 27530324 | 27530265 | GO:0005184(neuropeptide hormone activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0006954(inflammatory response);GO:0006979(response to oxidative stress);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007218(neuropeptide signaling pathway);GO:0007565(female pregnancy);GO:0007605(sensory perception of sound);GO:0008306(associative learning);GO:0009060(aerobic respiration);GO:0010629(negative regulation of gene expression);GO:0030157(pancreatic juice secretion);GO:0030307(positive regulation of cell growth);GO:0030425(dendrite);GO:0030819(positive regulation of cAMP biosynthetic process);GO:0031064(negative regulation of histone deacetylation);GO:0031175(neuron projection development);GO:0032099(negative regulation of appetite);GO:0032355(response to estradiol stimulus);GO:0032755(positive regulation of interleukin-6 production);GO:0032967(positive regulation of collagen biosynthetic process);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0034199(activation of protein kinase A activity);GO:0035176(social behavior);GO:0035483(gastric emptying);GO:0042756(drinking behavior);GO:0043066(negative regulation of apoptotic process);GO:0043117(positive regulation of vascular permeability);GO:0043196(varicosity);GO:0043204(perikaryon);GO:0043679(axon terminus);GO:0045727(positive regulation of translation);GO:0045740(positive regulation of DNA replication);GO:0045776(negative regulation of blood pressure);GO:0045792(negative regulation of cell size);GO:0045909(positive regulation of vasodilation);GO:0046811(histone deacetylase inhibitor activity);GO:0046888(negative regulation of hormone secretion);GO:0048265(response to pain);GO:0051384(response to glucocorticoid stimulus);GO:0051430(corticotropin-releasing hormone receptor 1 binding);GO:0051431(corticotropin-releasing hormone receptor 2 binding);GO:0051461(positive regulation of corticotropin secretion);GO:0051966(regulation of synaptic transmission, glutamatergic);GO:0060452(positive regulation of cardiac muscle contraction);GO:0060455(negative regulation of gastric acid secretion);GO:0060547(negative regulation of necrotic cell death);GO:0090280(positive regulation of calcium ion import);GO:2000252(negative regulation of feeding behavior);GO:2000987(positive regulation of behavioral fear response) | |
A_22_P00002714 | 10.71 | 10.27 | 10.35 | 12.15 | 11.87 | 11.74 | 0.88 | -0.19 | down | 0.00 | yes | ens|ENST00000437035|ens|ENST00000421257|linc|lnc-C20orf197-3:9|linc|lnc-C20orf197-3:10 | MIR646 host gene (non-protein coding) [Source:HGNC Symbol;Acc:HGNC:27659] [ENST00000437035] | chr20 | 58888386 | 58888445 | |||||
A_33_P3392537 | 9.33 | 9.30 | 9.65 | 6.84 | 7.08 | 7.68 | 1.31 | 0.39 | up | 0.00 | yes | ref|NM_004614|ref|NM_001172645|ref|NM_001172644|ref|NM_001172643 | 7084 | TK2 | thymidine kinase 2, mitochondrial | Homo sapiens thymidine kinase 2, mitochondrial (TK2), transcript variant 1, mRNA [NM_004614] | chr16 | 66543411 | 66543352 | GO:0004137(deoxycytidine kinase activity);GO:0004797(thymidine kinase activity);GO:0005524(ATP binding);GO:0005743(mitochondrial inner membrane);GO:0005759(mitochondrial matrix);GO:0006139(nucleobase-containing compound metabolic process);GO:0006206(pyrimidine base metabolic process);GO:0006264(mitochondrial DNA replication);GO:0009157(deoxyribonucleoside monophosphate biosynthetic process);GO:0009165(nucleotide biosynthetic process);GO:0009262(deoxyribonucleotide metabolic process);GO:0016310(phosphorylation);GO:0043097(pyrimidine nucleoside salvage);GO:0044281(small molecule metabolic process);GO:0046092(deoxycytidine metabolic process);GO:0046104(thymidine metabolic process);GO:0055086(nucleobase-containing small molecule metabolic process);GO:0071897(DNA biosynthetic process) | 00240(Pyrimidine metabolism|00983:Drug metabolism - other enzymes) |
A_22_P00004282 | 11.02 | 10.65 | 10.39 | 12.16 | 12.17 | 12.29 | 0.88 | -0.19 | down | 0.00 | yes | ref|NR_104131|ens|ENST00000456551|ens|ENST00000452922|linc|lnc-CNN3-3:8 | 101928079 | LINC01057 | long intergenic non-protein coding RNA 1057 | Homo sapiens long intergenic non-protein coding RNA 1057 (LINC01057), long non-coding RNA [NR_104131] | chr1 | 95123540 | 95123481 | ||
A_23_P370162 | 11 | 10.74 | 10.64 | 9.83 | 9.92 | 9.93 | 1.09 | 0.13 | up | 0.00 | yes | ref|NM_182969|ref|NM_001270381|ref|NM_001270380|ens|ENST00000531849 | 143570 | XRRA1 | X-ray radiation resistance associated 1 | Homo sapiens X-ray radiation resistance associated 1 (XRRA1), transcript variant 1, mRNA [NM_182969] | chr11 | 74552650 | 74552591 | GO:0003674(molecular_function);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0010165(response to X-ray) | |
A_23_P50697 | 9.85 | 9.52 | 10.12 | 8.02 | 8.39 | 8.12 | 1.20 | 0.27 | up | 0.00 | yes | ref|NM_006905|ref|NM_001297773|ref|NM_001184826|ref|NM_001184825 | 5669 | PSG1 | pregnancy specific beta-1-glycoprotein 1 | Homo sapiens pregnancy specific beta-1-glycoprotein 1 (PSG1), transcript variant 1, mRNA [NM_006905] | chr19 | 43372365 | 43372306 | GO:0005576(extracellular region);GO:0007565(female pregnancy) | |
A_21_P0004236 | 6.20 | 6.44 | 6.09 | 5.15 | 5.37 | 5.29 | 1.18 | 0.24 | up | 0.00 | yes | linc|lnc-C5orf17-1:2|linc|lnc-C5orf17-1:1|linc|TCONS_00009905|linc|TCONS_00009904 | lnc-C5orf17-1 | lnc-C5orf17-1:2 | LNCipedia lincRNA (lnc-C5orf17-1), lincRNA [lnc-C5orf17-1:2] | chr5 | 24321155 | 24321214 | |||
A_33_P3363485 | 10.09 | 9.99 | 10.19 | 10.54 | 10.58 | 10.56 | 0.96 | -0.07 | down | 0.00 | yes | ref|NM_018013|ens|ENST00000477448|ens|ENST00000618129|ens|ENST00000317357 | 55084 | SOBP | sine oculis binding protein homolog (Drosophila) | Homo sapiens sine oculis binding protein homolog (Drosophila) (SOBP), mRNA [NM_018013] | chr6 | 107827569 | 107827628 | GO:0007605(sensory perception of sound);GO:0007626(locomotory behavior);GO:0032184(SUMO polymer binding);GO:0042472(inner ear morphogenesis);GO:0046872(metal ion binding) | |
A_21_P0000812 | 5.92 | 5.87 | 5.72 | 6.36 | 6.50 | 6.40 | 0.91 | -0.14 | down | 0.00 | yes | ref|NR_038458|linc|lnc-WFIKKN2-1:1|gb|AK123714|tc|THC2511559 | 400604 | TOB1-AS1 | TOB1 antisense RNA 1 | Homo sapiens TOB1 antisense RNA 1 (TOB1-AS1), long non-coding RNA [NR_038458] | chr17 | 48945609 | 48945668 | ||
A_23_P139500 | 12.81 | 12.56 | 12.90 | 11 | 11.41 | 10.77 | 1.15 | 0.21 | up | 0.00 | yes | ref|NM_030762|ens|ENST00000242728|gb|AY665467|gb|BC025968 | 79365 | BHLHE41 | basic helix-loop-helix family, member e41 | Homo sapiens basic helix-loop-helix family, member e41 (BHLHE41), mRNA [NM_030762] | chr12 | 26273691 | 26273632 | GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001078(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001191(RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription);GO:0003705(RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006366(transcription from RNA polymerase II promoter);GO:0007623(circadian rhythm);GO:0008283(cell proliferation);GO:0009887(organ morphogenesis);GO:0010832(negative regulation of myotube differentiation);GO:0010944(negative regulation of transcription by competitive promoter binding);GO:0030154(cell differentiation);GO:0032922(circadian regulation of gene expression);GO:0042803(protein homodimerization activity);GO:0042826(histone deacetylase binding);GO:0043425(bHLH transcription factor binding);GO:0043426(MRF binding);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0046982(protein heterodimerization activity);GO:0070888(E-box binding) | 04710(Circadian rhythm) |
A_22_P00012354 | 5.20 | 5.38 | 5.42 | 6.27 | 6.20 | 6.55 | 0.84 | -0.25 | down | 0.00 | yes | linc|lnc-PRDX6-1:1 | lnc-PRDX6-1 | lnc-PRDX6-1:1 | LNCipedia lincRNA (lnc-PRDX6-1), lincRNA [lnc-PRDX6-1:1] | chr1 | 173572308 | 173572367 | |||
A_33_P3422233 | 9.24 | 9.14 | 8.85 | 9.99 | 10.11 | 10.04 | 0.90 | -0.15 | down | 0.00 | yes | ref|NM_020894|ens|ENST00000389851|ens|ENST00000503548|gb|AB040963 | 57654 | UVSSA | UV-stimulated scaffold protein A | Homo sapiens UV-stimulated scaffold protein A (UVSSA), mRNA [NM_020894] | chr4 | 1381673 | 1381732 | GO:0000993(RNA polymerase II core binding);GO:0005515(protein binding);GO:0005694(chromosome);GO:0006283(transcription-coupled nucleotide-excision repair);GO:0009411(response to UV);GO:0016567(protein ubiquitination) | |
A_21_P0005503 | 10.24 | 10.18 | 10.14 | 9.61 | 9.36 | 9.31 | 1.08 | 0.11 | up | 0.00 | yes | linc|lnc-SBDS-2:2|linc|TCONS_00013856 | lnc-SBDS-2 | lnc-SBDS-2:2 | LNCipedia lincRNA (lnc-SBDS-2), lincRNA [lnc-SBDS-2:2] | chr7 | 66798498 | 66798439 | |||
A_23_P40956 | 8.55 | 8.42 | 8.70 | 7.89 | 7.86 | 7.74 | 1.09 | 0.13 | up | 0.00 | yes | ref|NM_016362|ref|NM_001134941|ref|NM_001302821|ref|NM_001302822 | 51738 | GHRL | ghrelin/obestatin prepropeptide | Homo sapiens ghrelin/obestatin prepropeptide (GHRL), transcript variant 1, mRNA [NM_016362] | chr3 | 10327552 | 10327493 | GO:0000187(activation of MAPK activity);GO:0001664(G-protein coupled receptor binding);GO:0001696(gastric acid secretion);GO:0001937(negative regulation of endothelial cell proliferation);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005788(endoplasmic reticulum lumen);GO:0006006(glucose metabolic process);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007204(elevation of cytosolic calcium ion concentration);GO:0008154(actin polymerization or depolymerization);GO:0008343(adult feeding behavior);GO:0009725(response to hormone stimulus);GO:0009755(hormone-mediated signaling pathway);GO:0016358(dendrite development);GO:0016525(negative regulation of angiogenesis);GO:0016608(growth hormone-releasing hormone activity);GO:0030252(growth hormone secretion);GO:0030296(protein tyrosine kinase activator activity);GO:0030424(axon);GO:0031768(ghrelin receptor binding);GO:0032024(positive regulation of insulin secretion);GO:0032095(regulation of response to food);GO:0032100(positive regulation of appetite);GO:0032691(negative regulation of interleukin-1 beta production);GO:0034774(secretory granule lumen);GO:0040013(negative regulation of locomotion);GO:0040018(positive regulation of multicellular organism growth);GO:0042127(regulation of cell proliferation);GO:0042322(negative regulation of circadian sleep/wake cycle, REM sleep);GO:0042536(negative regulation of tumor necrosis factor biosynthetic process);GO:0043066(negative regulation of apoptotic process);GO:0043400(cortisol secretion);GO:0043627(response to estrogen stimulus);GO:0044267(cellular protein metabolic process);GO:0045409(negative regulation of interleukin-6 biosynthetic process);GO:0046010(positive regulation of circadian sleep/wake cycle, non-REM sleep);GO:0046676(negative regulation of insulin secretion);GO:0046697(decidualization);GO:0050728(negative regulation of inflammatory response);GO:0051216(cartilage development);GO:0051461(positive regulation of corticotropin secretion);GO:0051464(positive regulation of cortisol secretion);GO:0051965(positive regulation of synapse assembly);GO:0060079(regulation of excitatory postsynaptic membrane potential);GO:0060124(positive regulation of growth hormone secretion);GO:0060399(positive regulation of growth hormone receptor signaling pathway);GO:0061098(positive regulation of protein tyrosine kinase activity) | 04024(cAMP signaling pathway|04080:Neuroactive ligand-receptor interaction) |
document location:
summary/3_mRNA_differential_expression/*vs*/1_Diff_Analysis/*vs*_diff.xlsx
By using the volcano can understand the overall distribution of differentially expressed genes. Log2(foldchange) as the abscissa, representing the gene in different samples of the fold change in the fold; -log10(pvalue) as the ordinate, representing the gene expression differences in the statistical significance. In the figure, red indicates significant up-regulated differentially expressed genes, blue indicates significantly down-regulated significantly differentially expressed genes, and gray spots represent non-significantly differentially expressed genes.
document location:
summary/3_mRNA_differential_expression/*vs*/1_Diff_Analysis/*vs*_diff_volcano.png
Heatmap is a graphical representation of data where the individual z values (repeated) or Log10 (non-repeated) contained in a matrix are represented as color scheme. Calculation formula of z value is shown below. Sample-i means expression level(the value after normalization). In the figure, different colors represent different levels of gene expression, red indicates high expression genes and blue indicates low expression genes.
document location:
summary/3_mRNA_differential_expression/*vs*/1_Diff_Analysis/*vs*_diff_heatmap.png
Gene ontology (GO)(http://www.geneontology.org) is a major bioinformatics initiative to unify the representation of gene and gene product attributes across all species. More specifically, the project aims to: 1) maintain and develop its controlled vocabulary of gene and gene product attributes; 2) annotate genes and gene products, and assimilate and disseminate annotation data; and 3) provide tools for easy access to all aspects of the data provided by the project, and to enable functional interpretation of experimental data using the GO, for example via enrichment analysis.
GO is part of a larger classification effort, the Open Biomedical Ontologies (OBO).
Although gene nomenclature itself aims to maintain and develop controlled vocabulary of gene and gene products, the Gene Ontology extends the effort by using markup language to make the data (not only of the genes and their products but also of all their attributes) machine readable, and to do so in a way that is unified across all species (whereas gene nomenclature conventions vary by biologic taxon).
Significant GO terms were calculated by Hypergeometric equation as shown below. TB gene number=number of total genes; TS gene number=number of differentially expressed genes in total genes; B gene number=total number of gene in all GO terms; S gene number=number of differentially expressed genes in this GO term. Those GO terms with p value<0.05 were defined as significant GO terms.
Significant GO terms:
GO_ID | GO_Term | GO_function | GO_class | S gene number | TS gene number | B gene number | TB gene number | pvalue |
GO:0000786 | nucleosome | cellular_component | 12 | 33 | 1778 | 92 | 15922 | 3.95e-10 |
GO:0006271 | DNA strand elongation involved in DNA replication | biological_process | 11 | 13 | 1778 | 33 | 15922 | 2.66e-05 |
GO:0006334 | nucleosome assembly | biological_process | 12 | 27 | 1778 | 107 | 15922 | 3.42e-05 |
GO:0006298 | mismatch repair | biological_process | 10 | 12 | 1778 | 33 | 15922 | 0.00 |
GO:0000083 | regulation of transcription involved in G1/S phase of mitotic cell cycle | biological_process | 13 | 10 | 1778 | 25 | 15922 | 0.00 |
GO:0032201 | telomere maintenance via semi-conservative replication | biological_process | 11 | 10 | 1778 | 25 | 15922 | 0.00 |
GO:0006284 | base-excision repair | biological_process | 10 | 14 | 1778 | 45 | 15922 | 0.00 |
GO:0000723 | telomere maintenance | biological_process | 9 | 20 | 1778 | 80 | 15922 | 0.00 |
GO:0006281 | DNA repair | biological_process | 9 | 55 | 1778 | 317 | 15922 | 0.00 |
GO:0070182 | DNA polymerase binding | molecular_function | 6 | 5 | 1778 | 8 | 15922 | 0.00 |
GO:0000722 | telomere maintenance via recombination | biological_process | 10 | 10 | 1778 | 29 | 15922 | 0.00 |
GO:0007067 | mitosis | biological_process | 7 | 47 | 1778 | 268 | 15922 | 0.00 |
GO:0000278 | mitotic cell cycle | biological_process | 6 | 75 | 1778 | 476 | 15922 | 0.00 |
GO:0006260 | DNA replication | biological_process | 9 | 29 | 1778 | 145 | 15922 | 0.00 |
GO:0051461 | positive regulation of corticotropin secretion | biological_process | 12 | 3 | 1778 | 3 | 15922 | 0.00 |
GO:0032211 | negative regulation of telomere maintenance via telomerase | biological_process | 13 | 5 | 1778 | 9 | 15922 | 0.00 |
GO:0006270 | DNA-dependent DNA replication initiation | biological_process | 11 | 9 | 1778 | 27 | 15922 | 0.00 |
GO:0007044 | cell-substrate junction assembly | biological_process | 7 | 4 | 1778 | 6 | 15922 | 0.00 |
GO:0006285 | base-excision repair, AP site formation | biological_process | 9 | 5 | 1778 | 10 | 15922 | 0.00 |
GO:0022617 | extracellular matrix disassembly | biological_process | 6 | 24 | 1778 | 119 | 15922 | 0.00 |
GO:0051923 | sulfation | biological_process | 6 | 4 | 1778 | 7 | 15922 | 0.00 |
GO:0000777 | condensed chromosome kinetochore | cellular_component | 10 | 18 | 1778 | 83 | 15922 | 0.00 |
GO:0051539 | 4 iron, 4 sulfur cluster binding | molecular_function | 6 | 11 | 1778 | 41 | 15922 | 0.00 |
GO:0006289 | nucleotide-excision repair | biological_process | 10 | 18 | 1778 | 84 | 15922 | 0.00 |
GO:0003697 | single-stranded DNA binding | molecular_function | 8 | 19 | 1778 | 91 | 15922 | 0.01 |
GO:0021784 | postganglionic parasympathetic nervous system development | biological_process | 9 | 3 | 1778 | 4 | 15922 | 0.01 |
GO:2000643 | positive regulation of early endosome to late endosome transport | biological_process | 5 | 3 | 1778 | 4 | 15922 | 0.01 |
GO:0031262 | Ndc80 complex | cellular_component | 10 | 3 | 1778 | 4 | 15922 | 0.01 |
GO:0045007 | depurination | biological_process | 10 | 3 | 1778 | 4 | 15922 | 0.01 |
GO:0005658 | alpha DNA polymerase:primase complex | cellular_component | 13 | 3 | 1778 | 4 | 15922 | 0.01 |
GO:0021615 | glossopharyngeal nerve morphogenesis | biological_process | 11 | 3 | 1778 | 4 | 15922 | 0.01 |
GO:0032369 | negative regulation of lipid transport | biological_process | 7 | 3 | 1778 | 4 | 15922 | 0.01 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | biological_process | 10 | 22 | 1778 | 112 | 15922 | 0.01 |
GO:0051301 | cell division | biological_process | 5 | 55 | 1778 | 352 | 15922 | 0.01 |
GO:0046982 | protein heterodimerization activity | molecular_function | 6 | 63 | 1778 | 415 | 15922 | 0.01 |
GO:0017154 | semaphorin receptor activity | molecular_function | 6 | 5 | 1778 | 12 | 15922 | 0.01 |
GO:0071354 | cellular response to interleukin-6 | biological_process | 8 | 4 | 1778 | 8 | 15922 | 0.01 |
GO:0031681 | G-protein beta-subunit binding | molecular_function | 5 | 4 | 1778 | 8 | 15922 | 0.01 |
GO:0031100 | organ regeneration | biological_process | 8 | 11 | 1778 | 44 | 15922 | 0.01 |
GO:0032793 | positive regulation of CREB transcription factor activity | biological_process | 14 | 6 | 1778 | 17 | 15922 | 0.01 |
GO:0048009 | insulin-like growth factor receptor signaling pathway | biological_process | 10 | 6 | 1778 | 17 | 15922 | 0.01 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | biological_process | 11 | 7 | 1778 | 22 | 15922 | 0.01 |
GO:0005657 | replication fork | cellular_component | 11 | 7 | 1778 | 22 | 15922 | 0.01 |
GO:2000352 | negative regulation of endothelial cell apoptotic process | biological_process | 11 | 7 | 1778 | 22 | 15922 | 0.01 |
GO:0005814 | centriole | cellular_component | 10 | 19 | 1778 | 96 | 15922 | 0.01 |
GO:0006325 | chromatin organization | biological_process | 6 | 42 | 1778 | 261 | 15922 | 0.01 |
GO:0009165 | nucleotide biosynthetic process | biological_process | 9 | 5 | 1778 | 13 | 15922 | 0.01 |
GO:0033235 | positive regulation of protein sumoylation | biological_process | 12 | 5 | 1778 | 13 | 15922 | 0.01 |
GO:0006283 | transcription-coupled nucleotide-excision repair | biological_process | 11 | 13 | 1778 | 58 | 15922 | 0.01 |
GO:0000070 | mitotic sister chromatid segregation | biological_process | 8 | 7 | 1778 | 23 | 15922 | 0.01 |
GO:0006273 | lagging strand elongation | biological_process | 12 | 3 | 1778 | 5 | 15922 | 0.01 |
GO:0042799 | histone methyltransferase activity (H4-K20 specific) | molecular_function | 11 | 3 | 1778 | 5 | 15922 | 0.01 |
GO:0030911 | TPR domain binding | molecular_function | 6 | 3 | 1778 | 5 | 15922 | 0.01 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | biological_process | 10 | 3 | 1778 | 5 | 15922 | 0.01 |
GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process | biological_process | 10 | 3 | 1778 | 5 | 15922 | 0.01 |
GO:0051414 | response to cortisol stimulus | biological_process | 9 | 3 | 1778 | 5 | 15922 | 0.01 |
GO:0072015 | glomerular visceral epithelial cell development | biological_process | 11 | 3 | 1778 | 5 | 15922 | 0.01 |
GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway | biological_process | 7 | 3 | 1778 | 5 | 15922 | 0.01 |
GO:0008484 | sulfuric ester hydrolase activity | molecular_function | 6 | 3 | 1778 | 5 | 15922 | 0.01 |
GO:0050702 | interleukin-1 beta secretion | biological_process | 9 | 3 | 1778 | 5 | 15922 | 0.01 |
GO:0071897 | DNA biosynthetic process | biological_process | 8 | 8 | 1778 | 29 | 15922 | 0.01 |
GO:0002116 | semaphorin receptor complex | cellular_component | 6 | 4 | 1778 | 9 | 15922 | 0.01 |
GO:0051147 | regulation of muscle cell differentiation | biological_process | 8 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:0006272 | leading strand elongation | biological_process | 12 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:0004832 | valine-tRNA ligase activity | molecular_function | 8 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:0000727 | double-strand break repair via break-induced replication | biological_process | 12 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:0072144 | glomerular mesangial cell development | biological_process | 10 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:0008476 | protein-tyrosine sulfotransferase activity | molecular_function | 7 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:0031508 | centromeric heterochromatin assembly | biological_process | 13 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:0002086 | diaphragm contraction | biological_process | 11 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:0006478 | peptidyl-tyrosine sulfation | biological_process | 8 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:0034683 | alphav-beta3 integrin complex | cellular_component | 9 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:0006438 | valyl-tRNA aminoacylation | biological_process | 13 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:0050748 | negative regulation of lipoprotein metabolic process | biological_process | 7 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:2000766 | negative regulation of cytoplasmic translation | biological_process | 10 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process | biological_process | 12 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:0090188 | negative regulation of pancreatic juice secretion | biological_process | 9 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:0032226 | positive regulation of synaptic transmission, dopaminergic | biological_process | 11 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:0021793 | chemorepulsion of branchiomotor axon | biological_process | 10 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:0050923 | regulation of negative chemotaxis | biological_process | 6 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:0046104 | thymidine metabolic process | biological_process | 11 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:0032202 | telomere assembly | biological_process | 7 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:0004797 | thymidine kinase activity | molecular_function | 10 | 2 | 1778 | 2 | 15922 | 0.01 |
GO:0006206 | pyrimidine base metabolic process | biological_process | 9 | 7 | 1778 | 24 | 15922 | 0.01 |
GO:0000790 | nuclear chromatin | cellular_component | 13 | 26 | 1778 | 149 | 15922 | 0.01 |
GO:0005178 | integrin binding | molecular_function | 6 | 20 | 1778 | 107 | 15922 | 0.01 |
GO:0001974 | blood vessel remodeling | biological_process | 6 | 9 | 1778 | 36 | 15922 | 0.02 |
GO:0010811 | positive regulation of cell-substrate adhesion | biological_process | 6 | 10 | 1778 | 42 | 15922 | 0.02 |
GO:0007160 | cell-matrix adhesion | biological_process | 6 | 18 | 1778 | 94 | 15922 | 0.02 |
GO:0000086 | G2/M transition of mitotic cell cycle | biological_process | 8 | 28 | 1778 | 165 | 15922 | 0.02 |
GO:0014065 | phosphatidylinositol 3-kinase cascade | biological_process | 10 | 7 | 1778 | 25 | 15922 | 0.02 |
GO:1900034 | regulation of cellular response to heat | biological_process | 7 | 9 | 1778 | 37 | 15922 | 0.02 |
GO:0045806 | negative regulation of endocytosis | biological_process | 7 | 4 | 1778 | 10 | 15922 | 0.02 |
GO:0001921 | positive regulation of receptor recycling | biological_process | 9 | 4 | 1778 | 10 | 15922 | 0.02 |
GO:0045792 | negative regulation of cell size | biological_process | 7 | 4 | 1778 | 10 | 15922 | 0.02 |
GO:0006081 | cellular aldehyde metabolic process | biological_process | 5 | 4 | 1778 | 10 | 15922 | 0.02 |
GO:0016572 | histone phosphorylation | biological_process | 9 | 4 | 1778 | 10 | 15922 | 0.02 |
GO:0030166 | proteoglycan biosynthetic process | biological_process | 8 | 4 | 1778 | 10 | 15922 | 0.02 |
GO:0034260 | negative regulation of GTPase activity | biological_process | 15 | 4 | 1778 | 10 | 15922 | 0.02 |
document location:
summary/3_mRNA_differential_expression/*vs*/2_GO_Enrichment/*vs*_GO_enrichment.txt
Barplot of enriched GO terms:
document location:
summary/3_mRNA_differential_expression/*vs*/2_GO_Enrichment/*vs*_GO_enrichment.png
Scatterplot of enriched GO terms:
Number of differentially expressed genes enriched in GO terms, p value and rich factor are shown in scatterplot. Rich factor=(number of differentially expressed genes in GO term)/(total number of genes in GO term). The larger rich factor is, the higher enrichment is.
document location:
summary/3_mRNA_differential_expression/*vs*/2_GO_Enrichment/*vs*_GO_enrichment_scatterplot.png
KEGG (Kyoto Encyclopedia of Genes and Genomes) (http://www.kegg.jp/) is a collection of databases dealing with genomes, biological pathways, diseases, drugs, and chemical substances. KEGG is utilized for bioinformatics research and education, including data analysis in genomics, metagenomics, metabolomics and other omics studies, modeling and simulation in systems biology, and translational research in drug development.
Significant KEGG pathways were calculated by Hypergeometric equation as shown below. TB gene number=number of total genes; TS gene number=number of differentially expressed genes in total genes; B gene number=total number of genes in KEGG pathways; S gene number=number of differentially expressed genes in this KEGG pathway. Those KEGG pathways with p value<0.05 were defined as significant KEGG pathways.
Significant KEGG pathways:
pathway_id | pathway_name | S gene number | TS gene number | B gene number | TB gene number | pvalue |
ko05322 | Systemic lupus erythematosus | 13 | 713 | 30 | 5949 | 1.60e-05 |
ko03410 | Base excision repair | 9 | 713 | 26 | 5949 | 0.00 |
ko05203 | Viral carcinogenesis | 14 | 713 | 57 | 5949 | 0.01 |
ko05204 | Chemical carcinogenesis | 2 | 713 | 2 | 5949 | 0.01 |
ko03030 | DNA replication | 7 | 713 | 25 | 5949 | 0.02 |
ko04151 | PI3K-Akt signaling pathway | 19 | 713 | 102 | 5949 | 0.03 |
ko00052 | Galactose metabolism|04973:Carbohydrate digestion and absorption | 4 | 713 | 13 | 5949 | 0.06 |
ko00500 | Starch and sucrose metabolism | 4 | 713 | 13 | 5949 | 0.06 |
ko00980 | Metabolism of xenobiotics by cytochrome P450 | 3 | 713 | 8 | 5949 | 0.06 |
ko01212 | Fatty acid metabolism|01040:Biosynthesis of unsaturated fatty acids | 10 | 713 | 50 | 5949 | 0.07 |
ko00240 | Pyrimidine metabolism | 7 | 713 | 31 | 5949 | 0.07 |
ko04142 | Lysosome | 13 | 713 | 70 | 5949 | 0.07 |
ko00480 | Glutathione metabolism | 6 | 713 | 28 | 5949 | 0.11 |
ko04071 | Sphingolipid signaling pathway | 4 | 713 | 16 | 5949 | 0.12 |
ko01220 | Degradation of aromatic compounds|00010:Glycolysis / Gluconeogenesis|00040:Pentose and glucuronate interconversions|00561:Glycerolipid metabolism | 1 | 713 | 1 | 5949 | 0.12 |
ko00010 | Glycolysis / Gluconeogenesis|00620:Pyruvate metabolism|00640:Propanoate metabolism|00270:Cysteine and methionine metabolism|04922:Glucagon signaling pathway | 6 | 713 | 29 | 5949 | 0.13 |
ko04921 | Oxytocin signaling pathway | 3 | 713 | 11 | 5949 | 0.14 |
ko00531 | Glycosaminoglycan degradation | 4 | 713 | 17 | 5949 | 0.14 |
ko00760 | Nicotinate and nicotinamide metabolism | 4 | 713 | 17 | 5949 | 0.14 |
ko04114 | Oocyte meiosis | 4 | 713 | 17 | 5949 | 0.14 |
ko04974 | Protein digestion and absorption | 6 | 713 | 30 | 5949 | 0.14 |
ko00512 | Mucin type O-glycan biosynthesis | 5 | 713 | 24 | 5949 | 0.15 |
ko04510 | Focal adhesion | 2 | 713 | 6 | 5949 | 0.16 |
ko04122 | Sulfur relay system | 2 | 713 | 6 | 5949 | 0.16 |
ko04140 | Regulation of autophagy | 4 | 713 | 18 | 5949 | 0.16 |
ko00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 4 | 713 | 18 | 5949 | 0.16 |
ko00310 | Lysine degradation | 8 | 713 | 45 | 5949 | 0.16 |
ko00562 | Inositol phosphate metabolism | 11 | 713 | 67 | 5949 | 0.17 |
ko00600 | Sphingolipid metabolism | 7 | 713 | 40 | 5949 | 0.20 |
ko04911 | Insulin secretion | 3 | 713 | 13 | 5949 | 0.20 |
ko00250 | Alanine, aspartate and glutamate metabolism | 3 | 713 | 13 | 5949 | 0.20 |
ko04612 | Antigen processing and presentation | 3 | 713 | 13 | 5949 | 0.20 |
ko04623 | Cytosolic DNA-sensing pathway | 2 | 713 | 7 | 5949 | 0.20 |
ko03320 | PPAR signaling pathway | 4 | 713 | 20 | 5949 | 0.21 |
ko03440 | Homologous recombination | 4 | 713 | 20 | 5949 | 0.21 |
ko04141 | Protein processing in endoplasmic reticulum | 23 | 713 | 161 | 5949 | 0.21 |
ko05223 | Non-small cell lung cancer | 1 | 713 | 2 | 5949 | 0.23 |
ko04916 | Melanogenesis | 1 | 713 | 2 | 5949 | 0.23 |
ko00053 | Ascorbate and aldarate metabolism|00562:Inositol phosphate metabolism | 1 | 713 | 2 | 5949 | 0.23 |
ko05012 | Parkinson's disease | 2 | 713 | 8 | 5949 | 0.25 |
ko03430 | Mismatch repair | 2 | 713 | 8 | 5949 | 0.25 |
ko03460 | Fanconi anemia pathway | 6 | 713 | 36 | 5949 | 0.26 |
ko04152 | AMPK signaling pathway | 5 | 713 | 29 | 5949 | 0.26 |
ko00910 | Nitrogen metabolism | 3 | 713 | 15 | 5949 | 0.26 |
ko00051 | Fructose and mannose metabolism | 3 | 713 | 15 | 5949 | 0.26 |
ko00514 | Other types of O-glycan biosynthesis | 4 | 713 | 22 | 5949 | 0.27 |
ko00130 | Ubiquinone and other terpenoid-quinone biosynthesis | 2 | 713 | 9 | 5949 | 0.29 |
ko00260 | Glycine, serine and threonine metabolism | 3 | 713 | 16 | 5949 | 0.30 |
ko04972 | Pancreatic secretion | 3 | 713 | 16 | 5949 | 0.30 |
ko02010 | ABC transporters | 7 | 713 | 46 | 5949 | 0.31 |
ko04360 | Axon guidance | 11 | 713 | 77 | 5949 | 0.31 |
ko00785 | Lipoic acid metabolism | 1 | 713 | 3 | 5949 | 0.32 |
ko04932 | Non-alcoholic fatty liver disease (NAFLD) | 1 | 713 | 3 | 5949 | 0.32 |
ko05169 | Epstein-Barr virus infection | 1 | 713 | 3 | 5949 | 0.32 |
ko04330 | Notch signaling pathway | 6 | 713 | 39 | 5949 | 0.32 |
ko00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 3 | 713 | 17 | 5949 | 0.33 |
ko04970 | Salivary secretion | 3 | 713 | 18 | 5949 | 0.37 |
ko04110 | Cell cycle | 7 | 713 | 49 | 5949 | 0.37 |
ko04620 | Toll-like receptor signaling pathway | 2 | 713 | 11 | 5949 | 0.39 |
ko00630 | Glyoxylate and dicarboxylate metabolism | 2 | 713 | 11 | 5949 | 0.39 |
ko00511 | Other glycan degradation | 2 | 713 | 11 | 5949 | 0.39 |
ko03018 | RNA degradation | 8 | 713 | 58 | 5949 | 0.39 |
ko00603 | Glycosphingolipid biosynthesis - globo series | 1 | 713 | 4 | 5949 | 0.40 |
ko04940 | Type I diabetes mellitus | 1 | 713 | 4 | 5949 | 0.40 |
ko04270 | Vascular smooth muscle contraction | 2 | 713 | 12 | 5949 | 0.43 |
ko05110 | Vibrio cholerae infection | 1 | 713 | 5 | 5949 | 0.47 |
ko04973 | Carbohydrate digestion and absorption | 1 | 713 | 5 | 5949 | 0.47 |
ko01210 | 2-Oxocarboxylic acid metabolism|01230:Biosynthesis of amino acids|00330:Arginine and proline metabolism | 1 | 713 | 5 | 5949 | 0.47 |
ko00071 | Fatty acid degradation | 1 | 713 | 5 | 5949 | 0.47 |
ko00970 | Aminoacyl-tRNA biosynthesis | 5 | 713 | 38 | 5949 | 0.49 |
ko04014 | Ras signaling pathway | 26 | 713 | 214 | 5949 | 0.50 |
ko00790 | Folate biosynthesis | 2 | 713 | 14 | 5949 | 0.51 |
ko04962 | Vasopressin-regulated water reabsorption | 2 | 713 | 14 | 5949 | 0.51 |
ko04975 | Fat digestion and absorption | 1 | 713 | 6 | 5949 | 0.54 |
ko04723 | Retrograde endocannabinoid signaling | 1 | 713 | 6 | 5949 | 0.54 |
ko00750 | Vitamin B6 metabolism | 1 | 713 | 6 | 5949 | 0.54 |
ko05132 | Salmonella infection | 1 | 713 | 6 | 5949 | 0.54 |
ko03008 | Ribosome biogenesis in eukaryotes | 8 | 713 | 66 | 5949 | 0.54 |
ko00561 | Glycerolipid metabolism | 6 | 713 | 49 | 5949 | 0.54 |
ko00040 | Pentose and glucuronate interconversions | 2 | 713 | 15 | 5949 | 0.55 |
ko04146 | Peroxisome | 5 | 713 | 41 | 5949 | 0.56 |
ko05206 | MicroRNAs in cancer | 4 | 713 | 33 | 5949 | 0.57 |
ko05014 | Amyotrophic lateral sclerosis (ALS) | 1 | 713 | 7 | 5949 | 0.59 |
ko04550 | Signaling pathways regulating pluripotency of stem cells | 4 | 713 | 34 | 5949 | 0.59 |
ko05166 | HTLV-I infection | 2 | 713 | 17 | 5949 | 0.62 |
ko04742 | Taste transduction | 2 | 713 | 17 | 5949 | 0.62 |
ko00604 | Glycosphingolipid biosynthesis - ganglio series | 1 | 713 | 8 | 5949 | 0.64 |
ko04919 | Thyroid hormone signaling pathway | 3 | 713 | 27 | 5949 | 0.64 |
ko04020 | Calcium signaling pathway | 11 | 713 | 99 | 5949 | 0.65 |
ko00280 | Valine, leucine and isoleucine degradation | 2 | 713 | 18 | 5949 | 0.65 |
ko05202 | Transcriptional misregulation in cancers | 10 | 713 | 91 | 5949 | 0.66 |
ko04015 | Rap1 signaling pathway | 10 | 713 | 92 | 5949 | 0.68 |
ko00860 | Porphyrin and chlorophyll metabolism | 2 | 713 | 19 | 5949 | 0.68 |
ko00450 | Selenocompound metabolism | 1 | 713 | 9 | 5949 | 0.68 |
ko05162 | Measles | 1 | 713 | 9 | 5949 | 0.68 |
ko00670 | One carbon pool by folate | 1 | 713 | 9 | 5949 | 0.68 |
ko00140 | Steroid hormone biosynthesis | 3 | 713 | 30 | 5949 | 0.72 |
ko04144 | Endocytosis | 15 | 713 | 140 | 5949 | 0.72 |
ko00920 | Sulfur metabolism | 1 | 713 | 10 | 5949 | 0.72 |
document location:
summary/3_mRNA_differential_expression/*vs*/3_KEGG_Enrichment/*vs*_KEGG_enrichment.txt
Scatterplot of enriched KEGG pathways:
Number of differentially expressed genes enriched in KEGG pathway, p value and rich factor are shown in scatterplot. Rich factor=(number of differentially expressed genes in KEGG pathway)/(total number of genes in KEGG pathway). The larger rich factor is, the higher enrichment is.
document location:
summary/3_mRNA_differential_expression/*vs*/3_KEGG_Enrichment/*vs*_KEGG_enrichment_scatterplot.png
KEGG pathway maps:
Graphical map objects
The KEGG pathway map is a moleculalr interaction/reaction network diagram represented in terms of the KEGG Orthology (KO) groups, so that experimental evidence in specific organisms can be generalized to other organisms through genomic information. Each map is manually drawn with in-house software called KegSketch, which generates the KGML+ file. This file is an SVG file containing graphics objects that are associated with KEGG objects (see KEGG object identifiers). Basic graphics objects in the reference KEGG pathway maps are:
boxes - ortholog (KO) groups identified by K numbers and, in metabolic maps, reactions identified by R numbers as well
circles - other molecules, usually chemical compounds identified by C numbers, but including glycans identified by G numbers
lines - reactions identified by R numbers in metabolic maps; ortholog (KO) groups identified by K numbers in global metabolism maps
and in organism specific pathway maps that are computationally generated:
boxes - genes or gene products identified by the combination of the KEGG organism code and gene identifiers
These map objects can be searched in the search box at the top of the KEGG PATHWAY page, in the search box in each pathway map, and by the KEGG Mapper tools.
Convention of map number prefix
Each pathway map is identified by the combination of 2-4 letter code and 5 digit number (see KEGG Identifiers). The prefix has the following meaning:
map - Reference pathway
ko - Reference pathway (KO)
ec - Reference pathway (EC)
rn - Reference pathway (Reaction)
org - Organism-specific pathway map
Only the first reference pathway map is manually drawn; all other maps are computationally generated. For metabolic pathways, each box (or line) in the reference map is linked to the K number (KO identifeir), the EC number, and the R number (reaction identifier). The KO, EC, and reaction maps are linked to only one of them. For all metabolic and non-metabolic maps, K numbers are converted to gene identifiers in each organism to generate organism-specific pathways.
As shown above, "map" pathways are not colored, "ko/ec/rn" pathways are colored blue, and organism-specific pathways are colored green, where coloring indicates that map objects exist and are linked to corresponding entries. For global metabolism maps, "map" pathways are fully colored, so that "ko/ec/rn" pathways and organism-specific pathways are generated by reducing the coloring indicating the absence of corresponding entries.
In this study,all KEGG pathway maps were deposited in summary/3_mRNA_differential_expression/*vs*/3_KEGG_Enrichment/pathway_pics/
2575 West Bellfort Street
Suite 270
Houston, TX
77054 USA
Local (713) 664-7087
Toll Free: 1-888-528-8818
Fax: (713) 664-8181